LIEBER INSTITUTE INC
Reduce your risk when donating: see where the money actually goes.
Reduce your risk when donating: see where the money actually goes.
Cite this
Plain text LIEBER INSTITUTE INC. furp.org, nonprofit organization profile, tax years 2011–2024. https://furp.org/org/lieber-institute-inc-263690883. Retrieved 2026-11-22.
APA furp.org. (n.d.). LIEBER INSTITUTE INC [Nonprofit organization profile; tax years 2011–2024]. Retrieved November 22, 2026, from https://furp.org/org/lieber-institute-inc-263690883
MLA “LIEBER INSTITUTE INC.” furp.org, tax years 2011–2024, https://furp.org/org/lieber-institute-inc-263690883. Accessed 22 Nov. 2026.
Retrieved 2026-11-22; covers tax years 2011–2024. Data: furp.org (index © the FURP Alliance; the records are public domain).
About (Wikipedia)
Lieber Institute for Brain Development · US research center
The Lieber Institute for Brain Development (LIBD) is a nonprofit research center located in Baltimore, Maryland, that studies brain development issues such as schizophrenia and autism.
- Founded
- 2010
- Type
- research center
- Website
- http://www.libd.org/
From Wikipedia, CC BY-SA 4.0 (authors and history); facts from Wikidata (CC0). Matched by the same website address and the same name. Report a wrong match · About this data
2024 · Form 990 · revenue $33.2M ($34.0M in 2025 dollars) · expenses $35.2M · assets $35.4M
- EIN
- 26-3690883
- Address
- 855 NORTH WOLFE STREET SUITE 323, BALTIMORE, MD 21205-1503
- Website
- LIBD.ORG
- NTEE code
- H48 Brain Disorders Research (Medical Research) published (IRS Business Master File)
- FURP topic
- science: research education (from its 990 text; the topic index)
- Exempt type
- 501(c)(3): charitable, religious, educational, scientific or literary (corporation)
- Ruling date
- July 2009 (when the IRS recognized its exemption)
- IRS status
- Exempt (unconditional) (IRS Business Master File) IRS data ↗
- Tax-deductible donations
- Yes: listed in IRS Publication 78 (public charity) Pub 78 ↗
- Foundation status
- Hospital or medical research organization
- Principal officer
- Constance Lieber (its 2008 Form 990-N)
- Form 990-N e-postcards
- 1 filed, 2008 (organizations with gross receipts normally $50,000 or less file this instead of a full Form 990) IRS data ↗
- Cross-check
- ProPublica Nonprofit Explorer
Mission
THE MISSION OF THE INSTITUTE IS TO TRANSLATE BASIC GENETIC AND MOLECULAR MECHANISMS OF SCHIZOPHRENIA AND RELATED DEVELOPMENTAL BRAIN DISORDERS INTO CLINICAL ADVANCES THAT CHANGE THE LIVES OF AFFECTED INDIVIDUALS. IT IS CATALYZING A NEW UNDERSTANDING OF BRAIN DISEASE BY LINKING ADVANCES IN THE CONSTRUCTION AND FUNCTION OF THE HUMAN BRAIN WITH THE DEVELOPMENT OF NOVEL THERAPEUTIC STRATEGIES.
Each tax year counts once: when a return was amended, only the latest return for that period is used below (superseded returns stay listed, greyed, under Finances).
People paid by the organization
27 people paid across every filing: current people first, then by total pay from this organization. Organizations counts every nonprofit each person appears on.
| Name | Latest title | Years | Latest year pay | Total pay from here | Organizations |
|---|---|---|---|---|---|
| Daniel R Weinberger | CEO & DIRECTOR | 2011-2024 | $791,111 | $9,220,185 | 2 |
| Thomas Michael Hyde | CHIEF MEDICAL OFFICER | 2011-2024 | $454,629 | $5,452,919 | 2 |
| Joel E Kleinman | ASSOC. DIR. OF CLINICAL SC | 2013-2024 | $235,557 | $4,544,068 | 2 |
| Andrew Maslan | CFO & TREASURER | 2014-2024 | $404,940 | $3,997,565 | 1 |
| Elaine Jones | CHIEF OPERATING OFFICER | 2016-2024 | $468,968 | $3,408,825 | 1 |
| James Barrow | ASSOC. DIR. OF DRUG DISCOV | 2011-2024 | $350,713 | $3,261,469 | 1 |
| Brady Maher | LEAD INVESTIGATOR | 2019-2024 | $257,460 | $1,395,173 | 1 |
| Keri Martinowich | LEAD INVESTIGATOR | 2020-2024 | $323,384 | $1,247,147 | 1 |
| Jean Dubose | CHIEF OF STAFF | 2023-2024 | $248,509 | $486,752 | 2 |
| Geoff Delizzio | CHIEF ADVANCEMENT OFFICER | 2024 | $298,160 | $298,160 | 1 |
| Ron McKay (former) | Director of Basic Sciences | 2011-2016 | $390,072 | $2,268,123 | 1 |
| Venkata Satyanand Mattay (former) | FORMER ASSOC. DIR. OF NEUROIMAGIN | 2012-2019 | $187,034 | $2,239,202 | 1 |
| Kari L Stoever (former) | FORMER CHIEF EXT. RELATIONS OFFIC | 2016-2020 | $188,282 | $1,362,259 | 1 |
| Richard Straub (former) | SR. RESEARCH SCIENTIST | 2011-2021 | $211,411 | $1,293,722 | 1 |
| John Meyers (former) | DIRECTOR, IT & DB MGMT. | 2012-2020 | $206,302 | $733,015 | 1 |
| Shizhong Han (former) | LEAD INVESTIGATOR, DATA SC | 2021-2023 | $232,218 | $690,711 | 1 |
| Jim Barrow (former) | ASSOC. DIR. of drug discovery | 2012-2014 | $238,056 | $685,024 | 1 |
| Ronald Mckay (former) | FORMER DIRECTOR OF BASIC SCIENCES | 2017-2019 | $113,984 | $682,200 | 1 |
| Tara Eskandari (former) | CHIEF ADMINISTRTIVE OFFICER | 2011-2015 | $215,943 | $471,519 | 2 |
| Andrew Jaffe (former) | FORMER LEAD INVESTIGATOR | 2019-2020 | $191,779 | $436,208 | 1 |
| Yuan Gao (former) | INVESTIGATOR | 2011-2012 | $189,754 | $383,905 | 1 |
| Fengyu Zhang (former) | INVESTIGATOR | 2013-2014 | $171,099 | $334,403 | 1 |
| Gregory Carr (former) | LEAD INVESTIGATOR | 2022 | $222,754 | $222,754 | 1 |
| Jie Zhang (former) | INVESTIGATOR | 2013 | $165,389 | $165,389 | 1 |
| Yankai Jia (former) | INVESTIGATOR | 2014 | $157,256 | $157,256 | 1 |
| Xi Cheng (former) | INVESTIGATOR | 2012 | $150,108 | $150,108 | 1 |
| Yolanda Dudley (former) | ASSOCIATE CONTROLLER | 2011 | $124,793 | $124,793 | 1 |
Officers and directors, no compensation reported
21 people listed on the returns with $0 (or no amount) in every compensation column: current people first. Hours are as filed on the latest return each person appears on.
| Name | Latest title | Years | Hrs/wk (latest) | Compensation | Organizations |
|---|---|---|---|---|---|
| Steven Sharfstein Md | DIRECTOR | 2016-2024 | 1 | $0 reported | 6 |
| Geoffrey Simon | DIRECTOR | 2020-2024 | 1 | $0 reported | 2 |
| Mary Rubin | DIRECTOR | 2011-2024 | 1 | $0 reported | 2 |
| Tamar Maltz | DIRECTOR | 2011-2024 | 1 | $0 reported | 1 |
| Milton Maltz | DIRECTOR | 2011-2024 | 1 | $0 reported | 3 |
| Robert Muse | DIRECTOR | 2017-2024 | 1 | $0 reported | 1 |
| Landon S King | DIRECTOR | 2021-2024 | 1 | $0 reported | 1 |
| Ken Sonnenfeld | DIRECTOR | 2024 | 1 | $0 reported | 1 |
| Dan Browne | DIRECTOR | 2024 | 1 | $0 reported | 1 |
| Heidi Wagner | DIRECTOR | 2024 | 1 | $0 reported | 1 |
| Dr Herbert Pardes (former) | CHAIRMAN OF THE BOARD | 2011-2023 | 1 | $0 reported | 2 |
| Daniel R Getts (former) | DIRECTOR | 2021-2023 | 1 | $0 reported | 1 |
| Paul B Rothman Md (former) | DIRECTOR | 2018-2022 | 1 | $0 reported | 1 |
| Stephen Lieber (former) | DIRECTOR | 2016-2019 | 1 | $0 reported | 3 |
| Samuel Lieber (former) | PAST TREASURER | 2011-2018 | 1 | $0 reported | 2 |
| Ronald J Daniels (former) | Director | 2013-2017 | 1 | $0 reported | 1 |
| Steve Lieber (former) | DIRECTOR | 2011-2015 | 1 | $0 reported | 1 |
| Samual Lieber (former) | TREASURER | 2015 | 1 | $0 reported | 1 |
| Constance Lieber (former) | PRESIDENT/SECRETARY | 2011-2014 | 1 | $0 reported | 2 |
| Andrew Maslan See Sched O (former) | CHIEF FINANCIAL OFFICER & TREASURER | 2013 | 40 | $0 reported | 1 |
| Ron Daniels (former) | DIRECTOR | 2011 | 1 | $0 reported | 1 |
People by year
2024 · 20 people listed · 10 paid, $3.8M · 142 employees · 9 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| DANIEL R WEINBERGER | CEO & DIRECTOR | 40 | $762,004 | $0 | $29,107 | $791,111 | 2 |
| ELAINE JONES | CHIEF OPERATING OFFICER | 40 | $458,718 | $0 | $10,250 | $468,968 | 1 |
| THOMAS MICHAEL HYDE | CHIEF MEDICAL OFFICER | 40 | $425,522 | $0 | $29,107 | $454,629 | 2 |
| ANDREW MASLAN | CFO & TREASURER | 40 | $369,789 | $0 | $35,151 | $404,940 | 1 |
| JAMES BARROW | ASSOC. DIR. OF DRUG DISCOV | 40 | $315,562 | $0 | $35,151 | $350,713 | 1 |
| KERI MARTINOWICH | LEAD INVESTIGATOR | 40 | $288,375 | $0 | $35,009 | $323,384 | 1 |
| GEOFF DELIZZIO | CHIEF ADVANCEMENT OFFICER | 40 | $263,018 | $0 | $35,142 | $298,160 | 1 |
| BRADY MAHER | LEAD INVESTIGATOR | 40 | $223,132 | $0 | $34,328 | $257,460 | 1 |
| JEAN DUBOSE | CHIEF OF STAFF | 40 | $238,685 | $0 | $9,824 | $248,509 | 2 |
| JOEL E KLEINMAN | ASSOC. DIR. OF CLINICAL SC | 40 | $207,170 | $0 | $28,387 | $235,557 | 2 |
| KEN SONNENFELD | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| STEVEN SHARFSTEIN MD | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 6 |
| GEOFFREY SIMON | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 2 |
| MARY RUBIN | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 2 |
| TAMAR MALTZ | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| MILTON MALTZ | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 3 |
| ROBERT MUSE | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| DAN BROWNE | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| LANDON S KING | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| HEIDI WAGNER | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
2023 · 19 people listed · 10 paid, $3.8M · 136 employees · 9 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| DANIEL R WEINBERGER | CEO & DIRECTOR | 40 | $758,489 | $0 | $28,054 | $786,543 | 2 |
| THOMAS MICHAEL HYDE | CHIEF MEDICAL OFFICER | 40 | $425,980 | $0 | $28,054 | $454,034 | 2 |
| ELAINE JONES | CHIEF OPERATING OFFICER | 40 | $430,080 | $0 | $10,250 | $440,330 | 1 |
| ANDREW MASLAN | CFO & TREASURER | 40 | $357,638 | $0 | $33,598 | $391,236 | 1 |
| JOEL E KLEINMAN | ASSOC. DIR. OF CLINICAL SC | 40 | $358,560 | $0 | $28,054 | $386,614 | 2 |
| JAMES BARROW | ASSOC. DIR. OF DRUG DISCOV | 40 | $319,918 | $0 | $33,759 | $353,677 | 1 |
| KERI MARTINOWICH | LEAD INVESTIGATOR | 40 | $224,632 | $0 | $32,986 | $257,618 | 1 |
| JEAN DUBOSE | CHIEF OF STAFF | 40 | $228,486 | $0 | $9,757 | $238,243 | 2 |
| SHIZHONG HAN | LEAD INVESTIGATOR, DATA SC | 40 | $199,635 | $0 | $32,583 | $232,218 | 1 |
| BRADY MAHER | LEAD INVESTIGATOR | 40 | $197,647 | $0 | $32,880 | $230,527 | 1 |
| HERBERT PARDES MD | CHAIRMAN OF THE BOARD | 1 | $0 | $0 | $0 | $0 | 2 |
| STEVEN S SHARFSTEIN MD | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 6 |
| GEOFFREY SIMON | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 2 |
| MARY RUBIN | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 2 |
| TAMAR MALTZ | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| MILTON MALTZ | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 3 |
| ROBERT MUSE | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| DANIEL R GETTS | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| LANDON S KING | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
2022 · 20 people listed · 10 paid, $3.8M · 152 employees · 9 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| DANIEL R WEINBERGER | CEO & DIRECTOR | 40 | $763,001 | $0 | $26,761 | $789,762 | 2 |
| THOMAS MICHAEL HYDE | CHIEF MEDICAL OFFICER | 40 | $411,393 | $0 | $26,761 | $438,154 | 2 |
| ELAINE JONES | CHIEF OPERATING OFFICER | 40 | $414,835 | $0 | $10,250 | $425,085 | 1 |
| JOEL E KLEINMAN | ASSOC. DIR. OF CLINICAL SC | 40 | $397,458 | $0 | $26,761 | $424,219 | 2 |
| ANDREW MASLAN | CFO & TREASURER | 40 | $347,452 | $0 | $32,033 | $379,485 | 1 |
| JAMES BARROW | ASSOC. DIR. OF DRUG DISCOV | 40 | $337,058 | $0 | $32,049 | $369,107 | 1 |
| BRADY MAHER | LEAD INVESTIGATOR | 40 | $213,151 | $0 | $31,106 | $244,257 | 1 |
| KERI MARTINOWICH | LEAD INVESTIGATOR | 40 | $203,954 | $0 | $31,139 | $235,093 | 1 |
| SHIZHONG HAN | LEAD INVESTIGATOR, DATA SC | 40 | $197,004 | $0 | $30,931 | $227,935 | 1 |
| GREGORY CARR | LEAD INVESTIGATOR | 40 | $191,487 | $0 | $31,267 | $222,754 | 1 |
| HERBERT PARDES MD | CHAIRMAN OF THE BOARD | 1 | $0 | $0 | $0 | $0 | 2 |
| STEVEN S SHARFSTEIN MD | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 6 |
| PAUL B ROTHMAN MD | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| GEOFFREY SIMON | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 2 |
| MARY RUBIN | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 2 |
| TAMAR MALTZ | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| MILTON MALTZ | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 3 |
| ROBERT MUSE | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| DANIEL R GETTS | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| LANDON S KING | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
2021 · 20 people listed · 10 paid, $3.6M · 142 employees · 9 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| DANIEL R WEINBERGER | CEO & DIRECTOR | 40 | $733,926 | $0 | $25,559 | $759,485 | 2 |
| THOMAS MICHAEL HYDE | CHIEF MEDICAL OFFICER | 40 | $400,557 | $0 | $25,559 | $426,116 | 2 |
| ELAINE JONES | CHIEF OPERATING OFFICER | 40 | $402,589 | $0 | $10,250 | $412,839 | 1 |
| JOEL E KLEINMAN | ASSOC. DIR. OF CLINICAL SC | 40 | $386,209 | $0 | $25,559 | $411,768 | 2 |
| ANDREW MASLAN | CFO & TREASURER | 40 | $337,916 | $0 | $30,584 | $368,500 | 1 |
| JAMES BARROW | ASSOC. DIR. OF DRUG DISCOV | 40 | $304,433 | $0 | $30,462 | $334,895 | 1 |
| BRADY MAHER | LEAD INVESTIGATOR | 40 | $201,568 | $0 | $29,467 | $231,035 | 1 |
| SHIZHONG HAN | LEAD INVESTIGATOR, DATA SCIENCE | 40 | $201,271 | $0 | $29,287 | $230,558 | 1 |
| KERI MARTINOWICH | LEAD INVESTIGATOR | 40 | $190,229 | $0 | $29,438 | $219,667 | 1 |
| RICHARD STRAUB | SR. RESEARCH SCIENTIST | 40 | $195,351 | $0 | $16,060 | $211,411 | 1 |
| HERBERT PARDES MD | CHAIRMAN OF THE BOARD | 1 | $0 | $0 | $0 | $0 | 2 |
| STEVEN S SHARFSTEIN MD | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 6 |
| PAUL B ROTHMAN MD | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| GEOFFREY SIMON | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 2 |
| MARY RUBIN | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 2 |
| TAMAR MALTZ | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| MILTON MALTZ | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 3 |
| ROBERT MUSE | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| DANIEL R GETTS | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| LANDON S KING | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
2020 · 20 people listed · 12 paid, $3.9M · 135 employees · 9 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| DANIEL R WEINBERGER | CEO & DIRECTOR | 40 | $703,475 | $0 | $24,503 | $727,978 | 2 |
| THOMAS MICHAEL HYDE | CHIEF MEDICAL OFFICER | 40 | $402,184 | $0 | $24,503 | $426,687 | 2 |
| JOEL E KLEINMAN | ASSOC. DIR. OF CLINICAL SC | 40 | $389,504 | $0 | $24,503 | $414,007 | 2 |
| ELAINE JONES | CHIEF OPERATING OFFICER | 40 | $395,284 | $0 | $10,250 | $405,534 | 1 |
| ANDREW MASLAN | CFO & TREASURER | 40 | $334,684 | $0 | $30,902 | $365,586 | 1 |
| JAMES BARROW | ASSOC. DIR. OF DRUG DISCOV | 40 | $270,061 | $0 | $31,237 | $301,298 | 1 |
| BRADY MAHER | LEAD INVESTIGATOR | 40 | $184,981 | $0 | $30,303 | $215,284 | 1 |
| RICHARD STRAUB | SR. RESEARCH ASSISTANT | 40 | $195,878 | $0 | $16,167 | $212,045 | 1 |
| KERI MARTINOWICH | LEAD INVESTIGATOR | 40 | $181,501 | $0 | $29,884 | $211,385 | 1 |
| JOHN MEYERS | DIRECTOR, IT & DB MGMT. | 40 | $176,319 | $0 | $29,983 | $206,302 | 1 |
| ANDREW JAFFE | FORMER LEAD INVESTIGATOR | 40 | $176,416 | $0 | $15,363 | $191,779 | 1 |
| KARI L STOEVER | FORMER CHIEF EXT. RELATIONS OFFIC | 40 | $176,996 | $0 | $11,286 | $188,282 | 1 |
| HERBERT PARDES MD | CHAIRMAN OF THE BOARD | 1 | $0 | $0 | $0 | $0 | 2 |
| STEVEN S SHARFSTEIN MD | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 6 |
| PAUL B ROTHMAN MD | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| GEOFFREY SIMON | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 2 |
| MARY RUBIN | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 2 |
| TAMAR MALTZ | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| MILTON MALTZ | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 3 |
| ROBERT MUSE | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
2019 · 20 people listed · 12 paid, $3.9M · 153 employees · 9 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| DANIEL R WEINBERGER | CEO & DIRECTOR | 40 | $681,654 | $0 | $24,981 | $706,635 | 2 |
| THOMAS MICHAEL HYDE | CHIEF MEDICAL OFFICER | 40 | $399,073 | $0 | $25,072 | $424,145 | 2 |
| ANDREW MASLAN | CFO & TREASURER | 40 | $387,075 | $0 | $31,791 | $418,866 | 1 |
| JOEL E KLEINMAN | ASSOC. DIR. OF CLINICAL SC | 40 | $387,629 | $0 | $24,981 | $412,610 | 2 |
| ELAINE JONES | CHIEF OPERATING OFFICER | 40 | $388,882 | $0 | $11,261 | $400,143 | 1 |
| KARI L STOEVER | CHIEF EXT. RELATIONS OFFIC | 40 | $286,934 | $0 | $17,887 | $304,821 | 1 |
| JAMES BARROW | ASSOC. DIR. OF DRUG DISCOV | 40 | $247,385 | $0 | $31,487 | $278,872 | 1 |
| ANDREW JAFFE | LEAD INVESTIGATOR | 40 | $222,352 | $0 | $22,077 | $244,429 | 1 |
| BRADY MAHER | LEAD INVESTIGATOR | 40 | $186,038 | $0 | $30,572 | $216,610 | 1 |
| RICHARD STRAUB | SR. RESEARCH ASSISTANT | 40 | $187,714 | $0 | $16,796 | $204,510 | 1 |
| VENKATA SATYANAND MATTAY | FORMER ASSOC. DIR. OF NEUROIMAGIN | 22 | $168,275 | $0 | $18,759 | $187,034 | 1 |
| RONALD MCKAY | FORMER DIRECTOR OF BASIC SCIENCES | 10 | $113,846 | $0 | $138 | $113,984 | 1 |
| HERBERT PARDES MD | CHAIRMAN OF THE BOARD | 1 | $0 | $0 | $0 | $0 | 2 |
| STEVEN S SHARFSTEIN MD | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 6 |
| STEPHEN LIEBER | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 3 |
| MARY RUBIN | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 2 |
| TAMAR MALTZ | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| MILTON MALTZ | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 3 |
| PAUL B ROTHMAN MD | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| ROBERT MUSE | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
2018 · 18 people listed · 9 paid, $3.4M · 134 employees · 9 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| DANIEL R WEINBERGER | CEO & DIRECTOR | 40 | $685,256 | $0 | $33,528 | $718,784 | 2 |
| THOMAS MICHAEL HYDE | CHIEF MEDICAL OFFICER | 40 | $371,275 | $0 | $30,986 | $402,261 | 2 |
| JOEL E KLEINMAN | ASSOC. DIR. OF CLINICAL SCIENCE | 40 | $355,522 | $0 | $33,528 | $389,050 | 2 |
| ELAINE JONES | CHIEF OPERATING OFFICER | 40 | $367,794 | $0 | $10,250 | $378,044 | 1 |
| ANDREW MASLAN | CFO & TREASURER | 40 | $314,822 | $0 | $32,965 | $347,787 | 1 |
| VENKATA SATYANAND MATTAY | ASSOC. DIR. OF NEUROIMAGING CORE | 40 | $266,649 | $0 | $44,629 | $311,278 | 1 |
| KARI L STOEVER | CHIEF EXT. RELATIONS OFFICER | 40 | $280,296 | $0 | $18,140 | $298,436 | 1 |
| JAMES BARROW | ASSOC. DIR. OF DRUG DISCOVERY | 40 | $242,510 | $0 | $31,885 | $274,395 | 1 |
| RONALD MCKAY | DIRECTOR OF BASIC SCIENCES | 40 | $243,924 | $0 | $10,704 | $254,628 | 1 |
| HERBERT PARDES MD | CHAIRMAN OF THE BOARD | 1 | $0 | $0 | $0 | $0 | 2 |
| STEVEN S SHARFSTEIN MD | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 6 |
| STEPHEN LIEBER | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 3 |
| MARY RUBIN | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 2 |
| SAMUEL LIEBER | PAST TREASURER | 1 | $0 | $0 | $0 | $0 | 2 |
| TAMAR MALTZ | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| MILTON MALTZ | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 3 |
| PAUL B ROTHMAN MD | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| ROBERT MUSE | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
2017 · 18 people listed · 9 paid, $3.3M · 126 employees · 8 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| Daniel R Weinberger | CEO & Director | 40 | $672,190 | $0 | $26,994 | $699,184 | 2 |
| Thomas Michael Hyde | Chief Medical Officer | 40 | $362,116 | $0 | $27,160 | $389,276 | 2 |
| Joel E Kleinman | Assoc. Dir of Clinical Science | 40 | $346,503 | $0 | $26,994 | $373,497 | 2 |
| Elaine Jones | Chief Operating Officer | 40 | $350,000 | $0 | $10,905 | $360,905 | 1 |
| Andrew Maslan | CFO & Treasurer | 40 | $308,188 | $0 | $30,371 | $338,559 | 1 |
| Ronald McKay | Director of Basic Sciences | 40 | $302,608 | $0 | $10,980 | $313,588 | 1 |
| Venkata Satyanand Mattay | Assoc Dir of NeuroImaging Core | 40 | $260,645 | $0 | $33,968 | $294,613 | 1 |
| Kari L Stoever | Chief Ext. Relations Officer | 40 | $273,313 | $0 | $17,216 | $290,529 | 1 |
| JAMES Barrow | Assoc Dir of Drug Discovery | 40 | $236,252 | $0 | $30,683 | $266,935 | 1 |
| Herbert Pardes MD | Chairman of the Board | 1 | $0 | $0 | $0 | $0 | 2 |
| Ronald J Daniels | Director | 1 | $0 | $0 | $0 | $0 | 1 |
| Steven S Sharfstein MD | Director | 1 | $0 | $0 | $0 | $0 | 6 |
| Stephen Lieber | Director | 1 | $0 | $0 | $0 | $0 | 3 |
| Mary Rubin | Director | 1 | $0 | $0 | $0 | $0 | 2 |
| Samuel Lieber | Treasurer | 1 | $0 | $0 | $0 | $0 | 2 |
| Tamar Maltz | Director | 1 | $0 | $0 | $0 | $0 | 1 |
| Milton Maltz | Director | 1 | $0 | $0 | $0 | $0 | 3 |
| ROBERT MUSE | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
2016 · 17 people listed · 9 paid, $3.2M · 131 employees · 0 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| Daniel Weinberger | CEO & DIRECTOR | 40 | $642,003 | $0 | $61,783 | $703,786 | 2 |
| Ron McKay | Director of Basic Sciences | 40 | $378,999 | $0 | $11,073 | $390,072 | 1 |
| Joel Kleinman | Assoc. Dir of Clinical ScIENCE | 40 | $341,558 | $0 | $33,335 | $374,893 | 2 |
| Thomas M Hyde | Chief Medical Officer | 40 | $338,831 | $0 | $29,994 | $368,825 | 2 |
| Andrew Maslan | CFO & TREASURER | 40 | $315,000 | $0 | $33,020 | $348,020 | 1 |
| Venkata Mattay | Assoc.Dir of NeuroImaginG CORE | 40 | $260,564 | $0 | $42,781 | $303,345 | 1 |
| Kari Stoever | Chief Ext. Relations OfficER | 40 | $268,300 | $0 | $11,891 | $280,191 | 1 |
| James Barrow | Assoc. Dir of Drug DiscovERY | 40 | $233,431 | $0 | $32,402 | $265,833 | 1 |
| ELAINE JONES | Chief Operating Officer | 40 | $116,667 | $0 | $310 | $116,977 | 1 |
| Herbert Pardes MD | Chairman of the Board | 1 | $0 | $0 | $0 | $0 | 2 |
| Ronald J Daniels | Director | 1 | $0 | $0 | $0 | $0 | 1 |
| Steven S Sharfstein MD | Director | 1 | $0 | $0 | $0 | $0 | 6 |
| Stephen Lieber | Director | 1 | $0 | $0 | $0 | $0 | 3 |
| Mary Rubin | Director | 1 | $0 | $0 | $0 | $0 | 2 |
| Samuel Lieber | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 2 |
| Tamar Maltz | Director | 1 | $0 | $0 | $0 | $0 | 1 |
| Milton Maltz | Director | 1 | $0 | $0 | $0 | $0 | 3 |
2015 · 15 people listed · 8 paid, $2.9M · 126 employees · 0 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| DANIEL WEINBERGER | CEO & DIRECTOR | 40 | $603,651 | $0 | $30,628 | $634,279 | 2 |
| RON MCKAY | DIRECTOR OF BASIC SCIENCES | 40 | $378,999 | $0 | $11,204 | $390,203 | 1 |
| JOEL KLEINMAN | ASSOC. DIR OF CLINICAL SCIENCE | 40 | $335,250 | $0 | $31,219 | $366,469 | 2 |
| THOMAS M HYDE | COO & SECRETARY | 40 | $324,329 | $0 | $29,506 | $353,835 | 2 |
| ANDREW MASLAN | CFO & TREASURER | 40 | $302,083 | $0 | $31,706 | $333,789 | 1 |
| VENKATA MATTAY | INVESTIGATOR | 40 | $261,564 | $0 | $41,073 | $302,637 | 1 |
| JAMES BARROW | ASSOC. DIR OF DRUG DISCOVERY | 40 | $229,760 | $0 | $31,678 | $261,438 | 1 |
| TARA ESKANDARI | CHIEF ADMINISTRTIVE OFFICER | 40 | $203,775 | $0 | $12,168 | $215,943 | 2 |
| HERBERT PARDES MD | CHAIRMAN OF THE BOARD | 1 | $0 | $0 | $0 | $0 | 2 |
| RONALD J DANIELS | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| STEVE LIEBER | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| SAMUAL LIEBER | TREASURER | 1 | $0 | $0 | $0 | $0 | 1 |
| MARY RUBIN | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 2 |
| TAMAR MALTZ | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| MILTON MALTZ | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 3 |
2014 · 19 people listed · 11 paid, $3.2M · 126 employees · 0 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| DANIEL WEINBERGER | CEO & director | 40 | $553,785 | $0 | $41,697 | $595,482 | 2 |
| RON MCKAY | DIRECTOR OF BASIC SCIENCES | 40 | $376,136 | $0 | $11,194 | $387,330 | 1 |
| JOEL KLEINMAN | ASSOC. DIR.OF CLINcl sciences | 40 | $337,352 | $0 | $29,499 | $366,851 | 2 |
| THOMAS M HYDE | COO & secretary | 40 | $336,955 | $0 | $27,887 | $364,842 | 2 |
| ANDREW MASLAN | CFO & treasurer | 40 | $272,861 | $0 | $27,936 | $300,797 | 1 |
| VENKATA MATTAY | INVESTIGATOR | 40 | $246,073 | $0 | $38,287 | $284,360 | 1 |
| JIM BARROW | ASSOC. DIR. of drug discovery | 40 | $207,766 | $0 | $30,290 | $238,056 | 1 |
| RICHARD STRAUB | INVESTIGATOR | 40 | $162,175 | $0 | $28,236 | $190,411 | 1 |
| JOHN MEYERS | DIRECTOR OF IT | 40 | $152,670 | $0 | $29,562 | $182,232 | 1 |
| FENGYU ZHANG | INVESTIGATOR | 40 | $145,352 | $0 | $25,747 | $171,099 | 1 |
| YANKAI JIA | INVESTIGATOR | 40 | $149,774 | $0 | $7,482 | $157,256 | 1 |
| HERBERT PARDES MD | CHAIRMAN OF THE BOARD | 1 | $0 | $0 | $0 | $0 | 2 |
| RONALD J DANIELS | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| STEVE LIEBER | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| CONSTANCE LIEBER | PRESIDENT/SECRETARY | 1 | $0 | $0 | $0 | $0 | 2 |
| SAMUEL LIEBER | TREASURER | 1 | $0 | $0 | $0 | $0 | 2 |
| MARY RUBIN | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 2 |
| TAMAR MALTZ | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| MILTON MALTZ | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 3 |
2013 · 19 people listed · 10 paid, $2.8M · 106 employees · 0 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| DANIEL R WEINBERGER | CHIEF EXECUTIVE OFFICER & DIRECTOR | 40 | $502,420 | $0 | $16,526 | $518,946 | 2 |
| JOEL KLEINMAN | ASSOCIATE DIRECTOR OF CLINICAL SCIENCES | 40 | $370,454 | $0 | $18,079 | $388,533 | 2 |
| RON MCKAY | DIRECTOR OF BASIC SCIENCES | 40 | $370,352 | $0 | $16,394 | $386,746 | 1 |
| THOMAS M HYDE | CHIEF OPERATING OFFICER & SECRETARY | 40 | $316,071 | $0 | $25,862 | $341,933 | 2 |
| VENKATA MATTAY | INVESTIGATOR | 40 | $249,789 | $0 | $40,199 | $289,988 | 1 |
| JIM BARROW | ASSOCIATE DIRECTOR OF DRUG DISCOVERY | 40 | $197,907 | $0 | $30,993 | $228,900 | 1 |
| RICHARD STRAUB | INVESTIGATOR | 40 | $157,106 | $0 | $26,657 | $183,763 | 1 |
| JOHN MEYERS | DIRECTOR OF IT | 40 | $148,932 | $0 | $27,901 | $176,833 | 1 |
| JIE ZHANG | INVESTIGATOR | 40 | $156,032 | $0 | $9,357 | $165,389 | 1 |
| FENGYU ZHANG | INVESTIGATOR | 40 | $143,798 | $0 | $19,506 | $163,304 | 1 |
| HERBERT PARDES MD | CHAIRMAN OF THE BOARD | 1 | $0 | $0 | $0 | $0 | 2 |
| RONALD J DANIELS | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| STEVE LIEBER | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| CONSTANCE LIEBER | PRESIDENT/SECRETARY | 1 | $0 | $0 | $0 | $0 | 2 |
| SAMUEL LIEBER | TREASURER | 1 | $0 | $0 | $0 | $0 | 2 |
| MARY RUBIN | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 2 |
| TAMAR MALTZ | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| MILTON MALTZ | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 3 |
| ANDREW MASLAN SEE SCHED O | CHIEF FINANCIAL OFFICER & TREASURER | 40 | $0 | $0 | $0 | $0 | 1 |
2012 · 17 people listed · 10 paid, $2.5M · 75 employees · 0 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| DANIEL R WEINBERGER | DIRECTOR & CEO | 40 | $503,185 | $0 | $11,131 | $514,316 | 2 |
| RON MCKAY | DIRECTOR | 40 | $352,682 | $0 | $10,979 | $363,661 | 1 |
| THOMAS M HYDE | CHIEF OPERATING OFFICER | 40 | $284,679 | $0 | $21,474 | $306,153 | 2 |
| VENKATA MATTAY | INVESTIGATOR | 40 | $244,239 | $0 | $21,708 | $265,947 | 1 |
| JIM BARROW | INVESTIGATOR | 40 | $193,414 | $0 | $24,654 | $218,068 | 1 |
| YUAN GAO | INVESTIGATOR | 40 | $165,319 | $0 | $24,435 | $189,754 | 1 |
| RICHARD STRAUB | INVESTIGATOR | 40 | $153,133 | $0 | $24,212 | $177,345 | 1 |
| JOHN MEYERS | DIRECTOR/DB MANAGER | 40 | $147,635 | $0 | $20,013 | $167,648 | 1 |
| XI CHENG | INVESTIGATOR | 40 | $134,134 | $0 | $15,974 | $150,108 | 1 |
| TARA ESKANDARI | CHIEF ADMINISTRATIVE OFFICER | 40 | $116,780 | $0 | $10,033 | $126,813 | 2 |
| HERBERT PARDES MD | CHAIR | 1 | $0 | $0 | $0 | $0 | 2 |
| STEVE LIEBER | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| CONSTANCE LIEBER | PRESIDENT/SECRETARY | 1 | $0 | $0 | $0 | $0 | 2 |
| SAMUEL LIEBER | TREASURER | 1 | $0 | $0 | $0 | $0 | 2 |
| MARY RUBIN | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 2 |
| TAMAR MALTZ | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| MILTON MALTZ | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 3 |
2011 · 16 people listed · 8 paid, $1.7M · 47 employees · 0 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| RON MCKAY | DIRECTOR | 40 | $342,056 | $0 | $8,055 | $350,111 | 1 |
| THOMAS M HYDE MD PHD | CHIEF OPERATING OFFICER | 40 | $287,887 | $0 | $14,142 | $302,029 | 2 |
| DANIEL R WEINBERGER | DIRECTOR & CEO | 40 | $273,494 | $0 | $400 | $273,894 | 2 |
| JAMES BARROW | INVESTIGATOR | 40 | $188,583 | $0 | $15,723 | $204,306 | 1 |
| YUAN GAO | INVESTIGATOR | 40 | $178,567 | $0 | $15,584 | $194,151 | 1 |
| TARA ESKANDARI | CHIEF ADMIN. OFFICER | 40 | $122,937 | $0 | $5,826 | $128,763 | 2 |
| YOLANDA DUDLEY | ASSOCIATE CONTROLLER | 40 | $111,588 | $0 | $13,205 | $124,793 | 1 |
| RICHARD STRAUB | INVESTIGATOR | 40 | $103,654 | $0 | $10,583 | $114,237 | 1 |
| HERBERT PARDES MD | CHAIR | 1 | $0 | $0 | $0 | $0 | 2 |
| STEVE LIEBER | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| CONSTANCE LIEBER | PRESIDENT/SECRETARY | 1 | $0 | $0 | $0 | $0 | 2 |
| SAMUEL LIEBER | TREASURER | 1 | $0 | $0 | $0 | $0 | 2 |
| MARY RUBIN | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 2 |
| TAMAR MALTZ | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| MILTON MALTZ | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 3 |
| RON DANIELS | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
Highest-paid independent contractors
2024 · 1 contractor · $236K
| Name | Location | Service | Paid |
|---|---|---|---|
| REBECCA FREEDMAN | PIKESVILLE, MD | LEGAL SERVICES | $235,558 |
2023 · 1 contractor · $132K
| Name | Location | Service | Paid |
|---|---|---|---|
| ALVIN HATHAWAY | BALTIMORE, MD | COMMUNITY OUTREACH CONSULTING | $132,000 |
2022 · 2 contractors · $252K
| Name | Location | Service | Paid |
|---|---|---|---|
| ALVIN HATHAWAY | BALTIMORE, MD | COMMUNITY OUTREACH CONSULTING | $132,000 |
| RYAN CUMMINS | FRNKLIN, TN | COMMUNICATIONS CONSULTING | $120,000 |
2020 · 1 contractor · $120K
| Name | Location | Service | Paid |
|---|---|---|---|
| GETTS CONSULTING AND PROJECT MANAGEMENT | STOW, MA | CONSULTING | $120,000 |
2018 · 1 contractor · $188K
| Name | Location | Service | Paid |
|---|---|---|---|
| ARNOLD AND PORTER | WASHINGTON, DC | LEGAL SERVICES | $187,502 |
2017 · 1 contractor · $296K
| Name | Location | Service | Paid |
|---|---|---|---|
| ARNOLD AND PORTER | WASHINGTON, DC | $295,630 |
2016 · 1 contractor · $163K
| Name | Location | Service | Paid |
|---|---|---|---|
| EE JONES GROUP LLC | BALTIMORE, MD | STRATEGIC PLANNING | $163,148 |
2015 · 1 contractor · $177K
| Name | Location | Service | Paid |
|---|---|---|---|
| ELAINE JONES | BALTIMORE, MD | STRATEGIC PLANNING | $177,323 |
2014 · 2 contractors · $692K
| Name | Location | Service | Paid |
|---|---|---|---|
| KING AND SPALDING LLP | ATLANTA, GA | LEGAL SERVICES | $442,671 |
| arnold and porter llp | BALTIMORE, MD | LEGAL SERVICES | $248,940 |
2013 · 3 contractors · $642K
| Name | Location | Service | Paid |
|---|---|---|---|
| KING AND SPALDING LLP | LEGAL | $336,800 | |
| ARNOLD & PORTER LLP | LEGAL | $191,452 | |
| SCD INFORMATION TECHNOLOGY | IT | $114,102 |
2012 · 4 contractors · $765K
| Name | Location | Service | Paid |
|---|---|---|---|
| KING AND SPALDING LLP | ATLANTA, GA | LEGAL | $336,800 |
| ARNOLD & PORTER | BALTIMORE, MD | LEGAL | $191,453 |
| TRINET | SAN LEANDRO, CA | PAYROLL AND BENEFITS | $123,123 |
| SCD INFORMATION TECHNOLOGY | COLUMBIA, MD | IT | $114,102 |
2011 · 1 contractor · $113K
| Name | Location | Service | Paid |
|---|---|---|---|
| ARNOLD & PORTER | BALTIMORE, MD | LEGAL | $113,470 |
Who the money went to
Grants this organization reported paying: Schedule I Part II of the Form 990, or the grants-paid list on the 990-PF. Open a year for every recipient. Recipients link to their own page when the grant names an EIN we have (990-PF grants list no EIN, so those link only on an exact, unique name and state). Grants to individuals are counted; their names are not shown.
2024 · 7 grants to organizations · $1.8M
2023 · 6 grants to organizations · $1.3M
2013 · 1 grant to organizations · $350K
Listed grants add up to $350,000; the return's “grants paid” expense line says $427,500. Returns can differ here (grants paid vs. accrued, items listed elsewhere); check the filing.
2012 · 1 grant to organizations · $350K
Listed grants add up to $350,000; the return's “grants paid” expense line says $450,000. Returns can differ here (grants paid vs. accrued, items listed elsewhere); check the filing.
2011 · 1 grant to organizations · $350K
Listed grants add up to $350,000; the return's “grants paid” expense line says $450,000. Returns can differ here (grants paid vs. accrued, items listed elsewhere); check the filing.
Negative amounts are returned or refunded grants; they are listed last and left out of the totals of grants paid.
Who gave
Contributor names are not public for this form type.
Public charities filing Form 990 or 990-EZ report large donors on Schedule B, but the IRS withholds their names and addresses from public copies. Private foundations (990-PF) are different: their contributors are public.
Finances
Newest first. Each filing: its name on one row, its figures on the row beneath. Greyed filings are superseded by a later return for the same period and are left out everywhere else on this page.
| Revenue | Expenses | Assets | Net assets | Contributions | Program revenue | Officer pay | Employees | Volunteers |
|---|---|---|---|---|---|---|---|---|
| 2024 · Form 990 | ||||||||
| $33,169,343 | $35,235,311 | $35,367,628 | $22,941,871 | $23,732,564 | $8,727,987 | $2,494,217 | 142 | 9 |
| 2023 · Form 990 | ||||||||
| $31,261,351 | $32,639,037 | $35,095,508 | $23,602,603 | $27,627,150 | $1,856,612 | $2,446,984 | 136 | 9 |
| 2022 · Form 990 | ||||||||
| $28,903,115 | $31,448,930 | $36,656,603 | $23,965,665 | $26,098,672 | $1,749,804 | $2,410,907 | 152 | 9 |
| 2021 · Form 990 | ||||||||
| $22,894,222 | $29,512,998 | $31,106,210 | $25,304,996 | $16,080,378 | $2,921,001 | $2,342,466 | 142 | 9 |
| 2020 · Form 990 | ||||||||
| $35,823,160 | $27,198,424 | $44,686,565 | $36,807,990 | $24,381,597 | $10,291,170 | $2,325,026 | 135 | 9 |
| 2019 · Form 990 | ||||||||
| $17,247,195 | $28,499,790 | $32,856,647 | $25,980,515 | $11,440,375 | $3,261,242 | $2,258,338 | 153 | 9 |
| 2018 · Form 990 | ||||||||
| $21,791,141 | $26,379,595 | $44,500,781 | $38,747,057 | $14,851,678 | $2,607,520 | $1,859,997 | 134 | 9 |
| 2017 · Form 990 | ||||||||
| $20,649,548 | $26,899,975 | $52,981,874 | $45,622,734 | $9,537,511 | $5,087,929 | $1,855,666 | 126 | 8 |
| 2016 · Form 990 | ||||||||
| $14,340,702 | $23,935,074 | $60,320,805 | $54,943,995 | $6,953,598 | $2,155,884 | $1,487,942 | 131 | 0 |
| 2015 · Form 990 | ||||||||
| $12,934,930 | $23,755,734 | $66,206,784 | $60,021,337 | $7,352,088 | $4,406,147 | $1,310,436 | 126 | 0 |
| 2014 · Form 990 | ||||||||
| $11,803,016 | $22,379,478 | $79,790,463 | $72,430,516 | $3,257,427 | $6,311,029 | $2,107,520 | 126 | 0 |
| 2013 · Form 990 | ||||||||
| $9,034,813 | $20,660,464 | $91,491,249 | $84,448,958 | $441,315 | $5,000,506 | $1,867,189 | 106 | 0 |
| 2012 · Form 990 | ||||||||
| $2,866,597 | $15,799,963 | $100,309,339 | $94,668,311 | $150,000 | $527,526 | $1,584,142 | 75 | 0 |
| 2011 · Form 990 | ||||||||
| $4,184,007 | $11,000,339 | $112,679,813 | $107,532,319 | $953,521 | $549,532 | $1,500,664 | 47 | 0 |
Connected to
Organizations that list some of the same people on their returns (officers, directors, key employees on this organization’s latest return), and related organizations it lists on Schedule R.
- SHEPPARD PRATT - LIEBER RESEARCH Baltimore, MD · 5 people in common (Daniel R Weinberger, Jean Dubose, Joel E Kleinman)
- ESSEL FOUNDATION INC Purchase, NY · 2 people in common (Geoffrey Simon, Mary Rubin)
- SHEPPARD PRATT HEALTH SYSTEM INC Baltimore, MD · 1 person in common (Steven Sharfstein Md)
- FAMILY SERVICES INC Gaithersburg, MD · 1 person in common (Steven Sharfstein Md)
- NATIONAL ALLIANCE FOR RESEARCH ON SCHIZOPHRENIA AND DEPRESSION INC New York, NY · 1 person in common (Milton Maltz)
- SHEPPARD PRATT INVESTMENT INC Baltimore, MD · 1 person in common (Steven Sharfstein Md)
- SHEPPARD AND ENOCH PRATT FOUNDATION INC Baltimore, MD · 1 person in common (Steven Sharfstein Md)
- PARDES HUMANITARIAN PRIZE INC New York, NY · 1 person in common (Milton Maltz)
Funders of this organization
18 grantors reported grants to this organization, $35,386,170 in all, tax years 2012 to 2025. Exact: the grantor wrote this organization's EIN. Fuzzy: the grantor wrote only a name (foundations' 990-PF has no EIN field), matched to the same or a near-identical name in the same state; the name as filed is shown. From the latest return for each grantor and year, so amended returns aren't counted twice. CSV
| Grantor | Total given | Grants | Latest year's amount | Latest year | Years given | Type | Match | Grants |
|---|---|---|---|---|---|---|---|---|
| ESSEL FOUNDATION INC | $19,995,843 | 5 | $100,000 | 2016 | 2012-2016 | Private foundation | Fuzzy filed as “LIEBER INSTITUTE” | show |
| JOHNS HOPKINS UNIVERSITY | $8,878,881 | 11 | $498,615 | 2024 | 2014-2024 | DAF sponsor | Exact | show |
| MILTON & TAMAR MALTZ FAMILY FOUNDATION INC | $3,000,000 | 3 | $1,000,000 | 2023 | 2018-2019, 2023 | Private foundation | Fuzzy filed as “LIEBER INSTITUTE INC” | show |
| SILICON VALLEY COMMUNITY FOUNDATION | $1,000,000 | 1 | $1,000,000 | 2022 | 2022 | DAF sponsor | Exact | show |
| JEWISH FEDERATION OF CLEVELAND | $1,000,000 | 1 | $1,000,000 | 2022 | 2022 | DAF sponsor | Exact | show |
| YALE UNIVERSITY | $499,143 | 3 | $185,182 | 2024 | 2022-2024 | DAF sponsor | Exact | show |
| FIDELITY INVESTMENTS CHARITABLE GIFT FUND | $291,750 | 8 | $20,000 | 2024 | 2016-2019, 2021-2024 | DAF sponsor | Exact | show |
| NATIONAL ALLIANCE FOR RESEARCH ON SCHIZOPHRENIA AND DEPRESSION INC | $279,638 | 7 | $35,000 | 2024 | 2017-2018, 2020-2024 | Public charity | Exact | show |
| PITT HOPKINS RESEARCH FOUNDATION | $167,140 | 2 | $87,140 | 2018 | 2014, 2018 | Public charity | Exact | show |
| WEISMAN FAMILY FOUNDATION | $115,000 | 8 | $10,000 | 2025 | 2018-2025 | Private foundation | Fuzzy filed as “LIEBER INSTITUTE” | show |
| VANGUARD CHARITABLE ENDOWMENT PROGRAM | $75,000 | 1 | $75,000 | 2024 | 2024 | DAF sponsor | Exact | show |
| MAYO CLINIC | $36,790 | 1 | $36,790 | 2024 | 2024 | DAF sponsor | Exact | show |
| JUDY AND PETER BLUM KOVLER FOUNDATION | $25,000 | 3 | $10,000 | 2024 | 2022-2024 | Private foundation | Fuzzy filed as “LIEBER INSTITUTE” | show |
| DONOR ADVISED CHARITABLE GIVING | $10,000 | 1 | $10,000 | 2024 | 2024 | DAF sponsor | Exact | show |
| PAYPAL CHARITABLE GIVING FUND | $6,540 | 1 | $6,540 | 2023 | 2023 | DAF sponsor | Exact | show |
| SIDNEY M & PHYLLIS O BRESLER FOUNDATION INC | $5,000 | 1 | $5,000 | 2021 | 2021 | Private foundation | Fuzzy filed as “LIEBER INSTITUTE” | show |
| AMAZONSMILE FOUNDATION | $245 | 4 | $46 | 2023 | 2020-2023 | Private foundation | Fuzzy filed as “LIEBER INSTITUTE INC” | show |
| CARYL H AND BERNARD M SUSMAN FAMILY FOUNDATION | $200 | 1 | $200 | 2023 | 2023 | Private foundation | Fuzzy filed as “LIEBER INSTITUTE INC” | show |
Nearby + Similar BETA
Organizations like this one: what they do and who they are linked to
Same category: NTEE code and revenue
Ranked without any AI: same NTEE code first, then the same NTEE group; then revenue within 2x, 5x or 10x; then the same state; then similar name and mission text. NTEE: the IRS’s code when it lists one, otherwise FURP’s inferred code. Same state only · More (100)
| Organization | State | NTEE | Latest revenue | Latest expenses | Top-paid title | Top pay | Why similar |
|---|---|---|---|---|---|---|---|
| GLOBAL COALITION FOR ADAPTIVE RESEARCH INC | CA | H48 | $32,444,163 | $32,607,809 | CHIEF EXECUTIVE OFFICER/PRESIDENT | $1,321,615 | Same NTEE code H48, revenue within 2x |
| THE INTERNATIONAL ACADEMY OF HOPE | NY | H48 | $32,644,175 | $30,620,067 | BOARD CHAIRMAN/CEO OF YAI (DECEASED) | $765,420 | Same NTEE code H48, revenue within 2x |
| TISCH MULTIPLE SCLEROSIS RESEARCH CENTER OF NEW YORK INC | NY | H48 | $9,511,945 | $9,421,043 | SENIOR RESEARCH SCIENTIST | $272,103 | Same NTEE code H48, revenue within 5x |
| THE STANLEY MEDICAL RESEARCH INSTITUTE | MD | H48 | $6,297,768 | $6,719,202 | EXECUTIVE DIRECTOR | $278,759 | Same NTEE code H48, revenue within 10x, same state |
| DYSTONIA MEDICAL RESEARCH FOUNDATION | IL | H48 | $3,654,855 | $3,242,781 | Sec/EXEC DIR | $205,215 | Same NTEE code H48, revenue within 10x |
| PEDIATRIC BRAIN TUMOR FOUNDATION OF THE UNITED STATES INC | NC | H48 | $5,848,026 | $6,133,132 | CEO/President Through Sept 2024 | $341,249 | Same NTEE code H48, revenue within 10x |
| INSTITUTE OF CHRONIC ILLNESSES INC | MD | H48 | $32,633 | $33,100 | DIRECTOR | $0 | Same NTEE code H48, revenue differs more than 10x, same state |
| CORY HEIDARAN CHARITABLE FOUNDATION | MD | H48 | $11,175 | $6,138 | PhD | $0 | Same NTEE code H48, revenue differs more than 10x, same state |
| LANEY JAYMES FOUNDATION | MD | H48 | $1,676 | $11,633 | CEO Co-Chair | $0 | Same NTEE code H48, revenue differs more than 10x, same state |
| PEARL PSYCHEDELIC INSTITUTE | NC | H48 | $536,305 | $666,970 | EMPLOYEE | $73,006 | Same NTEE code H48, revenue differs more than 10x |
| NEURTEX BRAIN RESEARCH INSTITUTE INC | TX | H48 | $981,055 | $588,089 | PRESIDENT | $24,000 | Same NTEE code H48, revenue differs more than 10x |
| JUSTIN PARKER NEUROLOGICAL INSTITUTE | CO | H48 | $444,788 | $294,776 | Director of Research | $179,938 | Same NTEE code H48, revenue differs more than 10x |
| RARE HOPE INC | DC | H48 | $1,598,999 | $820,061 | PRESIDENT AND SECRETARY | $0 | Same NTEE code H48, revenue differs more than 10x |
| BRAIN CENTER OF GREEN BAY INC | WI | H48 | $182,342 | $355,512 | EXECUTIVE DIRECTOR | $121,820 | Same NTEE code H48, revenue differs more than 10x |
| KIMERA SOCIETY INC | FL | H48 | $195,567 | $276,132 | VICE PRESIDE | $0 | Same NTEE code H48, revenue differs more than 10x |
| FAMILIES FOR HOPE INC | IN | H48 | $36,078 | $66,143 | Secretary | $0 | Same NTEE code H48, revenue differs more than 10x |
| DAN LEWIS FOUNDATION FOR BRAIN REGENERATION RESEARCH | CO | H48 | $17,894 | $36,439 | Co-Chair | $0 | Same NTEE code H48, revenue differs more than 10x |
| SNYDER-ROBINSON FOUNDATION | VA | H48 | $68,211 | $14,181 | Director of Research | $2,136 | Same NTEE code H48, revenue differs more than 10x |
| NATHANIEL WHARTON FUND FOR RESEARCH IN BRAIN BODY AND BEHAVIOR INC | NY | H48 | $447,360 | $392,157 | TREASURER | $0 | Same NTEE code H48, revenue differs more than 10x |
| GRAYSON SAVES FOUNDATION INC | DE | H48 | $35,464 | $31,126 | CHAIRMAN | $0 | Same NTEE code H48, revenue differs more than 10x |
| CERECARE INC | CA | H48 | $450 | $475 | Chairman | $0 | Same NTEE code H48, revenue differs more than 10x |
| DR MARNIE ROSE FOUNDATION INC | TX | H48 | $386,022 | $377,546 | Co-Executive Director | $43,317 | Same NTEE code H48, revenue differs more than 10x |
| BOUNCE OUT THE STIGMA PROJECT INC | NJ | H48 | $197,279 | $174,429 | EXECUTIVE DIRECTOR | $64,000 | Same NTEE code H48, revenue differs more than 10x |
| ELIZABETH M FEHRENBACH TR UW FBO GEORGE B FEHRENBACH | FL | H48 | $55,935 | $101,097 | EXECUTIVE DI | $0 | Same NTEE code H48, revenue differs more than 10x |
| NEURONETWORKS FUND INC | CT | H48 | $41,247 | $26,135 | DIRECTOR, PRESIDENT, INVES | $0 | Same NTEE code H48, revenue differs more than 10x |
Who funds organizations like this
Grantors that funded the 100 most similar organizations. Ranked by total given to them. Foundations (990-PF) and donor-advised fund sponsors only. Same matching as Funders above (by EIN, or by name for foundations).
The full list · all similar organizations
Where the money went
Every expense line on each return, biggest first: Form 990 Part IX (with its program, management and fundraising columns), 990-EZ Part I, or 990-PF Part I. Event marks lines the organization itself describes as events. “Events” in each summary adds those lines, conferences and meetings, and the direct costs of fundraising events. Unusual is not the same as improper. Many of these patterns have ordinary explanations. Check the filing.
2024 · Form 990 · $35,235,311 spent · pay $17,913,019 · grants $1,847,613 · events $76,835
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $12,381,172 | $10,546,120 | $1,835,052 | - | 35.1% | |
| Occupancy | $3,410,892 | $2,648,100 | $762,792 | - | 9.7% | |
| Pay: officers, directors, trustees, key employees | $2,494,217 | $1,769,798 | $724,419 | - | 7.1% | |
| Other (as described) | OTHER LAB EXPENSES | $2,419,789 | $2,417,657 | $2,132 | - | 6.9% |
| Other (as described) | GENERAL LAB SUPPLIES | $2,270,792 | $2,270,498 | $294 | - | 6.4% |
| Other (as described) | LAB SERVICES | $2,028,569 | $2,026,592 | $1,977 | - | 5.8% |
| Grants to US organizations and governments | $1,847,613 | $1,847,613 | - | - | 5.2% | |
| Other employee benefits | $1,559,824 | $1,234,849 | $324,975 | - | 4.4% | |
| Office expenses | $1,292,359 | $1,035,476 | $256,883 | - | 3.7% | |
| Depreciation and depletion | $1,201,457 | $1,063,940 | $137,517 | - | 3.4% | |
| Fees: other services | $1,163,594 | $713,569 | $450,025 | - | 3.3% | |
| Payroll taxes | $950,260 | $737,044 | $213,216 | - | 2.7% | |
| Information technology | $872,421 | $720,427 | $151,994 | - | 2.5% | |
| Pension plan contributions | $527,546 | $425,465 | $102,081 | - | 1.5% | |
| Travel | $222,080 | $183,185 | $38,895 | - | 0.6% | |
| Fees: investment management | $140,700 | - | $140,700 | - | 0.4% | |
| Fees: legal | $128,445 | $19,720 | $108,725 | - | 0.4% | |
| All other expenses | $84,922 | $53,995 | $30,927 | - | 0.2% | |
| Insurance | $78,143 | - | $78,143 | - | 0.2% | |
| Conferences, conventions and meetings | $76,835 | $49,973 | $26,862 | - | 0.2% | |
| Fees: accounting | $64,177 | - | $64,177 | - | 0.2% | |
| Advertising and promotion | $19,504 | - | $19,504 | - | 0.1% | |
| Total | $35,235,311 | 100% |
2023 · Form 990 · $32,639,037 spent · pay $17,259,883 · grants $1,347,916 · events $64,635
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $11,852,362 | $10,014,844 | $1,837,518 | - | 36.3% | |
| Occupancy | $3,287,423 | $2,498,237 | $789,186 | - | 10.1% | |
| Other (as described) | GENERAL LAB SUPPLIES | $2,590,383 | $2,584,745 | $5,638 | - | 7.9% |
| Pay: officers, directors, trustees, key employees | $2,446,984 | $1,599,139 | $847,845 | - | 7.5% | |
| Other (as described) | OTHER LAB EXPENSES | $2,034,356 | $2,032,500 | $1,856 | - | 6.2% |
| Other employee benefits | $1,516,493 | $1,175,871 | $340,622 | - | 4.6% | |
| Depreciation and depletion | $1,370,328 | $1,214,394 | $155,934 | - | 4.2% | |
| Grants to US organizations and governments | $1,347,916 | $1,347,916 | - | - | 4.1% | |
| Other (as described) | LAB SERVICES | $1,287,181 | $1,286,644 | $537 | - | 3.9% |
| Office expenses | $1,256,465 | $1,039,975 | $216,490 | - | 3.8% | |
| Fees: other services | $1,126,675 | $907,040 | $219,635 | - | 3.5% | |
| Payroll taxes | $930,643 | $711,812 | $218,831 | - | 2.9% | |
| Pension plan contributions | $513,401 | $401,236 | $112,165 | - | 1.6% | |
| Information technology | $393,764 | $120,294 | $273,470 | - | 1.2% | |
| Travel | $241,983 | $185,975 | $56,008 | - | 0.7% | |
| Fees: investment management | $134,692 | - | $134,692 | - | 0.4% | |
| Insurance | $70,893 | - | $70,893 | - | 0.2% | |
| Conferences, conventions and meetings | $64,635 | $41,812 | $22,823 | - | 0.2% | |
| Other (as described) | OTHER EXPENSES | $50,799 | $9,614 | $41,185 | - | 0.2% |
| Fees: legal | $49,967 | $11,000 | $38,967 | - | 0.2% | |
| Fees: accounting | $42,870 | - | $42,870 | - | 0.1% | |
| Advertising and promotion | $28,824 | - | $28,824 | - | 0.1% | |
| Total | $32,639,037 | 100% |
2022 · Form 990 · $31,448,930 spent · pay $16,987,100 · grants $0 · events $62,178
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $11,689,439 | $10,154,142 | $1,535,297 | - | 37.2% | |
| Occupancy | $3,159,671 | $2,468,301 | $691,370 | - | 10.0% | |
| Other (as described) | OTHER LAB EXPENSES | $2,629,777 | $2,486,502 | $143,275 | - | 8.4% |
| Pay: officers, directors, trustees, key employees | $2,410,907 | $1,587,920 | $822,987 | - | 7.7% | |
| Other (as described) | GENERAL LAB SUPPLIES | $2,093,345 | $2,093,345 | - | - | 6.7% |
| Other (as described) | LAB SERVICES | $1,528,782 | $1,528,199 | $583 | - | 4.9% |
| Other employee benefits | $1,486,508 | $1,185,292 | $301,216 | - | 4.7% | |
| Office expenses | $1,235,559 | $1,024,670 | $210,889 | - | 3.9% | |
| Depreciation and depletion | $1,174,765 | $1,089,014 | $85,751 | - | 3.7% | |
| Fees: other services | $1,168,564 | $882,135 | $286,429 | - | 3.7% | |
| Payroll taxes | $909,441 | $712,934 | $196,507 | - | 2.9% | |
| Pension plan contributions | $490,805 | $394,308 | $96,497 | - | 1.6% | |
| Information technology | $330,588 | $159,680 | $170,908 | - | 1.1% | |
| Other (as described) | OTHER EXPENSES | $297,306 | $244,247 | $53,059 | - | 0.9% |
| Travel | $264,834 | $209,321 | $55,513 | - | 0.8% | |
| All other expenses | $137,142 | - | $137,142 | - | 0.4% | |
| Fees: lobbying | $105,000 | - | $105,000 | - | 0.3% | |
| Fees: legal | $96,806 | $47,336 | $49,470 | - | 0.3% | |
| Insurance | $74,419 | - | $74,419 | - | 0.2% | |
| Conferences, conventions and meetings | $62,178 | $36,952 | $25,226 | - | 0.2% | |
| Fees: accounting | $60,550 | - | $60,550 | - | 0.2% | |
| Advertising and promotion | $42,544 | - | $42,544 | - | 0.1% | |
| Total | $31,448,930 | 100% |
2021 · Form 990 · $29,512,998 spent · pay $15,511,810 · grants $0 · events $32,292
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $10,553,382 | $9,295,325 | $1,258,057 | - | 35.8% | |
| Occupancy | $3,300,122 | $2,573,391 | $726,731 | - | 11.2% | |
| Other (as described) | GENERAL LAB SUPPLIES | $2,964,606 | $2,957,302 | $7,304 | - | 10.0% |
| Pay: officers, directors, trustees, key employees | $2,342,466 | $1,550,769 | $791,697 | - | 7.9% | |
| Other (as described) | OTHER LAB EXPENSES | $1,756,752 | $1,754,051 | $2,701 | - | 6.0% |
| Other (as described) | LAB SERVICES | $1,377,305 | $1,375,823 | $1,482 | - | 4.7% |
| Other employee benefits | $1,318,843 | $1,054,830 | $264,013 | - | 4.5% | |
| Depreciation and depletion | $1,232,501 | $1,165,835 | $66,666 | - | 4.2% | |
| Fees: other services | $1,162,238 | $915,092 | $247,146 | - | 3.9% | |
| Office expenses | $1,135,424 | $956,280 | $179,144 | - | 3.8% | |
| Payroll taxes | $811,682 | $645,369 | $166,313 | - | 2.8% | |
| Pension plan contributions | $485,437 | $395,970 | $89,467 | - | 1.6% | |
| Information technology | $280,219 | $80,543 | $199,676 | - | 0.9% | |
| Other (as described) | OTHER EXPENSES | $189,339 | $33,193 | $156,146 | - | 0.6% |
| Travel | $144,972 | $109,579 | $35,393 | - | 0.5% | |
| Fees: legal | $110,440 | $851 | $109,589 | - | 0.4% | |
| Fees: accounting | $78,350 | - | $78,350 | - | 0.3% | |
| All other expenses | $66,150 | $41,150 | $25,000 | - | 0.2% | |
| Insurance | $61,688 | - | $61,688 | - | 0.2% | |
| Fees: lobbying | $52,500 | - | $52,500 | - | 0.2% | |
| Advertising and promotion | $51,491 | $500 | $50,991 | - | 0.2% | |
| Conferences, conventions and meetings | $32,292 | $31,687 | $605 | - | 0.1% | |
| Interest | $4,799 | - | $4,799 | - | 0.0% | |
| Total | $29,512,998 | 100% |
2020 · Form 990 · $27,198,424 spent · pay $13,957,160 · grants $0 · events $12,923
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $9,267,624 | $8,092,839 | $1,174,785 | - | 34.1% | |
| Occupancy | $3,463,127 | $2,718,807 | $744,320 | - | 12.7% | |
| Other (as described) | LAB SERVICES | $2,614,581 | $2,611,828 | $2,753 | - | 9.6% |
| Pay: officers, directors, trustees, key employees | $2,325,026 | $1,544,949 | $780,077 | - | 8.5% | |
| Other (as described) | GENERAL LAB SUPPLIES | $1,918,582 | $1,919,399 | -$817 | - | 7.1% |
| Depreciation and depletion | $1,690,228 | $1,512,986 | $177,242 | - | 6.2% | |
| Other employee benefits | $1,237,635 | $987,501 | $250,134 | - | 4.6% | |
| Fees: other services | $972,993 | $858,048 | $114,945 | - | 3.6% | |
| Office expenses | $883,300 | $756,486 | $126,814 | - | 3.2% | |
| Other (as described) | OTHER LAB EXPENSES | $825,938 | $824,477 | $1,461 | - | 3.0% |
| Payroll taxes | $738,373 | $585,398 | $152,975 | - | 2.7% | |
| Pension plan contributions | $388,502 | $317,639 | $70,863 | - | 1.4% | |
| Information technology | $309,176 | $116,450 | $192,726 | - | 1.1% | |
| Fees: legal | $279,707 | $350 | $279,357 | - | 1.0% | |
| Other (as described) | OTHER EXPENSES | $61,848 | $6,064 | $55,784 | - | 0.2% |
| Insurance | $58,921 | - | $58,921 | - | 0.2% | |
| Fees: accounting | $53,875 | - | $53,875 | - | 0.2% | |
| All other expenses | $35,346 | $32,846 | $2,500 | - | 0.1% | |
| Travel | $26,867 | $9,334 | $17,533 | - | 0.1% | |
| Advertising and promotion | $19,676 | - | $19,676 | - | 0.1% | |
| Interest | $14,176 | - | $14,176 | - | 0.1% | |
| Conferences, conventions and meetings | $12,923 | $12,183 | $740 | - | 0.0% | |
| Total | $27,198,424 | 100% |
2019 · Form 990 · $28,499,790 spent · pay $13,461,188 · grants $0 · events $37,504
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $8,876,746 | $7,356,178 | $1,520,568 | - | 31.1% | |
| Other (as described) | OTHER LAB EXPENSES | $4,901,500 | $4,937,561 | -$36,061 | - | 17.2% |
| Occupancy | $3,320,097 | $2,483,257 | $836,840 | - | 11.6% | |
| Pay: officers, directors, trustees, key employees | $2,258,338 | $1,441,252 | $817,086 | - | 7.9% | |
| Other (as described) | GENERAL LAB SUPPLIES | $2,046,784 | $1,983,510 | $63,274 | - | 7.2% |
| Depreciation and depletion | $1,744,169 | $1,520,867 | $223,302 | - | 6.1% | |
| Other employee benefits | $1,224,551 | $897,005 | $327,546 | - | 4.3% | |
| Fees: other services | $1,161,270 | $973,064 | $188,206 | - | 4.1% | |
| Office expenses | $931,783 | $750,956 | $180,827 | - | 3.3% | |
| Payroll taxes | $683,538 | $511,181 | $172,357 | - | 2.4% | |
| Pension plan contributions | $418,015 | $324,412 | $93,603 | - | 1.5% | |
| Information technology | $318,376 | $108,922 | $209,454 | - | 1.1% | |
| Travel | $195,253 | $100,926 | $94,327 | - | 0.7% | |
| Fees: legal | $110,935 | - | $110,935 | - | 0.4% | |
| All other expenses | $72,230 | $1,242 | $70,988 | - | 0.3% | |
| Fees: accounting | $70,350 | - | $70,350 | - | 0.2% | |
| Other (as described) | HONORARIA | $66,131 | $45,631 | $20,500 | - | 0.2% |
| Insurance | $64,206 | - | $64,206 | - | 0.2% | |
| Conferences, conventions and meetings | $37,504 | $36,018 | $1,486 | - | 0.1% | |
| Interest | $22,603 | - | $22,603 | - | 0.1% | |
| Advertising and promotion | $18,321 | - | $18,321 | - | 0.1% | |
| Other (as described) | MISCELLANEOUS EXPENSES | -$42,910 | - | -$42,910 | - | -0.2% |
| Total | $28,499,790 | 100% |
2018 · Form 990 · $26,379,595 spent · pay $13,026,928 · grants $100,000 · events $52,643
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $8,758,757 | $7,144,909 | $1,613,848 | - | 33.2% | |
| Other (as described) | OTHER LAB EXPENSES | $3,448,881 | $3,445,410 | $3,471 | - | 13.1% |
| Occupancy | $3,096,174 | $4,004,413 | -$908,239 | - | 11.7% | |
| Other (as described) | GENERAL LAB SUPPLIES | $2,369,637 | $2,342,224 | $27,413 | - | 9.0% |
| Pay: officers, directors, trustees, key employees | $1,859,997 | $1,127,055 | $732,942 | - | 7.1% | |
| Depreciation and depletion | $1,756,829 | $654,613 | $1,102,216 | - | 6.7% | |
| Other employee benefits | $1,354,840 | $1,099,551 | $255,289 | - | 5.1% | |
| Office expenses | $771,332 | $367,121 | $404,211 | - | 2.9% | |
| Fees: other services | $708,165 | $259,419 | $448,746 | - | 2.7% | |
| Payroll taxes | $619,935 | $505,709 | $114,226 | - | 2.4% | |
| Pension plan contributions | $433,399 | $338,280 | $95,119 | - | 1.6% | |
| Travel | $335,556 | $185,924 | $149,632 | - | 1.3% | |
| Information technology | $275,714 | $77,403 | $198,311 | - | 1.0% | |
| Grants to US individuals | $100,000 | $100,000 | - | - | 0.4% | |
| Fees: lobbying | $72,626 | - | $72,626 | - | 0.3% | |
| Fees: legal | $69,168 | - | $69,168 | - | 0.3% | |
| Fees: accounting | $65,716 | - | $65,716 | - | 0.2% | |
| All other expenses | $65,261 | $23,789 | $41,472 | - | 0.2% | |
| Insurance | $56,635 | - | $56,635 | - | 0.2% | |
| Conferences, conventions and meetings | $52,643 | $49,479 | $3,164 | - | 0.2% | |
| Other (as described) | MISCELLANEOUS EXPENSES | $37,844 | $30,871 | $6,973 | - | 0.1% |
| Other (as described) | RECRUITING | $36,902 | - | $36,902 | - | 0.1% |
| Interest | $25,119 | - | $25,119 | - | 0.1% | |
| Advertising and promotion | $8,465 | - | $8,465 | - | 0.0% | |
| Total | $26,379,595 | 100% |
2017 · Form 990 · $26,899,975 spent · pay $12,592,925 · grants $225,000 · events $68,392
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $8,633,308 | $7,118,936 | $1,514,372 | - | 32.1% | |
| Other (as described) | OTHER LAB EXPENSES | $4,692,031 | $4,689,065 | $2,966 | - | 17.4% |
| Occupancy | $2,871,765 | $3,738,825 | -$867,060 | - | 10.7% | |
| Other (as described) | GENERAL LAB SUPPLIES | $2,261,128 | $2,241,017 | $20,111 | - | 8.4% |
| Pay: officers, directors, trustees, key employees | $1,855,666 | $1,122,079 | $733,587 | - | 6.9% | |
| Depreciation and depletion | $1,784,678 | $655,158 | $1,129,520 | $0 | 6.6% | |
| Other employee benefits | $1,209,603 | $948,862 | $260,741 | - | 4.5% | |
| Office expenses | $709,900 | $425,469 | $284,431 | - | 2.6% | |
| Fees: other services | $581,444 | $178,878 | $402,566 | - | 2.2% | |
| Payroll taxes | $562,588 | $441,317 | $121,271 | - | 2.1% | |
| Fees: legal | $408,405 | -$3,584 | $411,989 | - | 1.5% | |
| Pension plan contributions | $331,760 | $260,246 | $71,514 | - | 1.2% | |
| Travel | $281,582 | $146,987 | $134,595 | - | 1.0% | |
| Grants outside the US | $225,000 | $225,000 | - | - | 0.8% | |
| Information technology | $189,021 | $42,629 | $146,392 | - | 0.7% | |
| Fees: accounting | $70,556 | - | $70,556 | - | 0.3% | |
| Conferences, conventions and meetings | $68,392 | $57,507 | $10,885 | - | 0.3% | |
| Insurance | $47,133 | - | $47,133 | - | 0.2% | |
| Interest | $29,822 | - | $29,822 | - | 0.1% | |
| Other (as described) | Other | $29,704 | $13,811 | $15,893 | - | 0.1% |
| All other expenses | $19,980 | - | $19,980 | - | 0.1% | |
| Advertising and promotion | $19,963 | - | $19,963 | - | 0.1% | |
| Other (as described) | Recruiting | $16,546 | - | $16,546 | - | 0.1% |
| Total | $26,899,975 | 100% |
2016 · Form 990 · $23,935,074 spent · pay $12,329,629 · grants $0 · events $53,406
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $8,615,715 | $6,978,057 | $1,637,658 | - | 36.0% | |
| Occupancy | $2,840,337 | $3,468,353 | -$628,016 | - | 11.9% | |
| Other (as described) | OTHER LAB EXPENSES | $2,410,988 | $2,407,210 | $3,778 | - | 10.1% |
| Depreciation and depletion | $1,972,187 | $902,021 | $1,070,166 | - | 8.2% | |
| Other (as described) | GENERAL LAB SUPPLIES | $1,698,229 | $1,662,653 | $35,576 | - | 7.1% |
| Pay: officers, directors, trustees, key employees | $1,487,942 | $785,275 | $702,667 | - | 6.2% | |
| Other employee benefits | $1,203,631 | $933,057 | $270,574 | - | 5.0% | |
| Office expenses | $876,411 | $463,583 | $412,828 | - | 3.7% | |
| Payroll taxes | $630,754 | $488,804 | $141,950 | - | 2.6% | |
| Fees: other services | $532,297 | $236,667 | $295,630 | - | 2.2% | |
| Fees: legal | $444,753 | - | $444,753 | - | 1.9% | |
| Pension plan contributions | $391,587 | $303,472 | $88,115 | - | 1.6% | |
| Travel | $303,869 | $160,273 | $143,596 | - | 1.3% | |
| Information technology | $232,810 | $55,994 | $176,816 | - | 1.0% | |
| Fees: accounting | $64,266 | - | $64,266 | - | 0.3% | |
| Conferences, conventions and meetings | $53,406 | $51,091 | $2,315 | - | 0.2% | |
| Insurance | $45,231 | - | $45,231 | $0 | 0.2% | |
| Interest | $37,778 | - | $37,778 | - | 0.2% | |
| Other (as described) | RECRUITING | $35,565 | - | $35,565 | - | 0.1% |
| Advertising and promotion | $24,288 | - | $24,288 | - | 0.1% | |
| Other (as described) | MISCELLANEOUS EXPENSES | $18,137 | $2,510 | $15,627 | - | 0.1% |
| All other expenses | $14,893 | - | $14,893 | - | 0.1% | |
| Total | $23,935,074 | 100% |
2015 · Form 990 · $23,755,734 spent · pay $12,119,478 · grants $0 · events $48,175
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $7,670,315 | $6,608,186 | $1,062,129 | - | 32.3% | |
| Occupancy | $2,792,772 | $3,541,582 | -$748,810 | - | 11.8% | |
| Other employee benefits | $2,226,997 | $1,764,468 | $462,529 | - | 9.4% | |
| Depreciation and depletion | $2,225,512 | $1,144,104 | $1,081,408 | - | 9.4% | |
| Other (as described) | GENERAL LAB SUPPLIES | $2,168,597 | $2,159,463 | $9,134 | - | 9.1% |
| Other (as described) | LAB EXPENSES | $1,891,006 | $1,886,952 | $4,054 | $0 | 8.0% |
| Pay: officers, directors, trustees, key employees | $1,310,436 | $270,197 | $1,040,239 | - | 5.5% | |
| Fees: other services | $871,403 | $363,518 | $507,885 | - | 3.7% | |
| Office expenses | $723,346 | $440,716 | $282,630 | - | 3.0% | |
| Payroll taxes | $582,154 | $468,654 | $113,500 | - | 2.5% | |
| Pension plan contributions | $329,576 | $275,669 | $53,907 | - | 1.4% | |
| Fees: legal | $244,144 | $800 | $243,344 | - | 1.0% | |
| Travel | $234,936 | $134,040 | $100,896 | - | 1.0% | |
| Information technology | $194,979 | $69,975 | $125,004 | - | 0.8% | |
| Other (as described) | OTHER EXPENSES | $113,801 | $3,398 | $110,403 | - | 0.5% |
| Fees: accounting | $63,798 | - | $63,798 | - | 0.3% | |
| Conferences, conventions and meetings | $48,175 | $45,115 | $3,060 | - | 0.2% | |
| Insurance | $47,727 | - | $47,727 | - | 0.2% | |
| Interest | $16,060 | $1,560 | $14,500 | - | 0.1% | |
| Total | $23,755,734 | 100% |
2014 · Form 990 · $22,379,478 spent · pay $11,462,985 · grants $75,000 · events $66,803
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $7,402,116 | $6,637,128 | $764,988 | - | 33.1% | |
| Occupancy | $2,528,681 | $3,363,114 | -$834,433 | - | 11.3% | |
| Depreciation and depletion | $2,149,987 | $1,157,059 | $992,928 | - | 9.6% | |
| Pay: officers, directors, trustees, key employees | $2,107,520 | $1,055,496 | $1,052,024 | - | 9.4% | |
| Other (as described) | LAB EXPENSES | $1,682,639 | $1,662,341 | $20,298 | - | 7.5% |
| Other (as described) | GENERAL LAB SUPPLIES | $1,661,070 | $1,651,538 | $9,532 | - | 7.4% |
| Other employee benefits | $1,114,067 | $939,682 | $174,385 | - | 5.0% | |
| Fees: other services | $883,654 | $469,672 | $413,982 | - | 3.9% | |
| Office expenses | $601,059 | $414,679 | $186,380 | - | 2.7% | |
| Payroll taxes | $554,340 | $457,349 | $96,991 | - | 2.5% | |
| Fees: legal | $433,694 | $711 | $432,983 | - | 1.9% | |
| Travel | $318,810 | $245,592 | $73,218 | - | 1.4% | |
| Pension plan contributions | $284,942 | $256,834 | $28,108 | - | 1.3% | |
| Information technology | $212,602 | $62,507 | $150,095 | - | 0.9% | |
| Other (as described) | OTHER EXPENSES | $132,406 | $60,509 | $71,897 | $0 | 0.6% |
| Fees: accounting | $75,201 | - | $75,201 | - | 0.3% | |
| Grants outside the US | $75,000 | $75,000 | - | - | 0.3% | |
| Conferences, conventions and meetings | $66,803 | $61,662 | $5,141 | - | 0.3% | |
| Interest | $52,566 | $6,341 | $46,225 | - | 0.2% | |
| Insurance | $42,321 | $252 | $42,069 | - | 0.2% | |
| Total | $22,379,478 | 100% |
2013 · Form 990 · $20,660,464 spent · pay $10,081,399 · grants $427,500 · events $35,111
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $6,590,122 | $6,091,707 | $498,415 | - | 31.9% | |
| Other (as described) | GENERAL LAB SUPPLIES | $2,302,946 | $2,294,506 | $8,440 | - | 11.1% |
| Occupancy | $2,227,558 | $2,827,783 | -$600,225 | - | 10.8% | |
| Depreciation and depletion | $1,910,257 | $1,067,938 | $842,319 | - | 9.2% | |
| Pay: officers, directors, trustees, key employees | $1,867,189 | $1,080,041 | $787,148 | - | 9.0% | |
| Other (as described) | OTHER LAB EXPENSE | $919,119 | $861,573 | $57,546 | - | 4.4% |
| Other employee benefits | $891,683 | $761,005 | $130,678 | - | 4.3% | |
| Fees: legal | $663,861 | $29,109 | $634,752 | - | 3.2% | |
| Fees: other services | $629,404 | $412,071 | $217,333 | - | 3.0% | |
| Office expenses | $611,093 | $383,166 | $227,927 | - | 3.0% | |
| Payroll taxes | $518,398 | $446,674 | $71,724 | - | 2.5% | |
| Travel | $438,075 | $291,572 | $146,503 | - | 2.1% | |
| Grants to US organizations and governments | $350,000 | $350,000 | - | - | 1.7% | |
| Pension plan contributions | $214,007 | $207,332 | $6,675 | - | 1.0% | |
| All other expenses | $148,796 | $35,172 | $113,624 | - | 0.7% | |
| Information technology | $84,704 | $21,131 | $63,573 | - | 0.4% | |
| Grants outside the US | $77,500 | $77,500 | - | - | 0.4% | |
| Fees: professional fundraisers | $50,000 | - | - | $50,000 | 0.2% | |
| Interest | $47,216 | $841 | $46,375 | - | 0.2% | |
| Fees: accounting | $43,640 | - | $43,640 | - | 0.2% | |
| Insurance | $39,785 | - | $39,785 | - | 0.2% | |
| Conferences, conventions and meetings | $35,111 | $13,210 | $21,901 | - | 0.2% | |
| Total | $20,660,464 | 100% |
2012 · Form 990 · $15,799,963 spent · pay $7,715,150 · grants $450,000 · events $66,605
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $4,964,297 | $4,515,264 | $449,033 | - | 31.4% | |
| Occupancy | $2,015,841 | $79,696 | $1,936,145 | - | 12.8% | |
| Other (as described) | GENERAL LAB SUPPLIES | $1,694,666 | $1,691,723 | $2,943 | - | 10.7% |
| Depreciation and depletion | $1,584,604 | $672,347 | $912,257 | - | 10.0% | |
| Pay: officers, directors, trustees, key employees | $1,584,142 | $1,103,938 | $480,204 | - | 10.0% | |
| Other employee benefits | $569,927 | $510,531 | $59,396 | - | 3.6% | |
| Payroll taxes | $455,728 | $398,974 | $56,754 | - | 2.9% | |
| Fees: legal | $452,811 | $82,177 | $370,634 | - | 2.9% | |
| Office expenses | $432,647 | $294,871 | $137,776 | - | 2.7% | |
| Grants to US organizations and governments | $350,000 | $350,000 | - | - | 2.2% | |
| Fees: other services | $327,923 | $94,892 | $233,031 | - | 2.1% | |
| Other (as described) | OTHER LAB EXPENSE | $246,654 | $246,654 | - | - | 1.6% |
| Information technology | $241,546 | $39,023 | $202,523 | - | 1.5% | |
| Travel | $180,789 | $141,493 | $39,253 | $43 | 1.1% | |
| All other expenses | $171,950 | $73,809 | $98,141 | - | 1.1% | |
| Pension plan contributions | $141,056 | $122,492 | $18,564 | - | 0.9% | |
| Grants outside the US | $100,000 | $100,000 | - | - | 0.6% | |
| Interest | $71,715 | $25,715 | $46,000 | - | 0.5% | |
| Conferences, conventions and meetings | $66,605 | $32,613 | $33,992 | - | 0.4% | |
| Fees: professional fundraisers | $65,000 | - | - | $65,000 | 0.4% | |
| Fees: accounting | $44,539 | - | $44,539 | - | 0.3% | |
| Insurance | $37,523 | $199 | $37,324 | - | 0.2% | |
| Total | $15,799,963 | 100% |
2011 · Form 990 · $11,000,339 spent · pay $5,175,377 · grants $450,000 · events $15,605
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $3,212,197 | $2,903,602 | $308,595 | - | 29.2% | |
| Pay: officers, directors, trustees, key employees | $1,500,664 | $1,045,765 | $454,899 | - | 13.6% | |
| Occupancy | $1,327,172 | $9,845 | $1,317,327 | - | 12.1% | |
| Depreciation and depletion | $1,089,081 | $570,170 | $518,911 | - | 9.9% | |
| Other (as described) | GENERAL LAB SUPPLIES | $995,787 | $992,934 | $2,853 | - | 9.1% |
| Payroll taxes | $369,854 | $311,720 | $58,134 | - | 3.4% | |
| Grants to US organizations and governments | $350,000 | $350,000 | - | - | 3.2% | |
| Office expenses | $331,869 | $235,426 | $96,443 | - | 3.0% | |
| Fees: legal | $311,405 | $48,703 | $262,702 | - | 2.8% | |
| Information technology | $275,469 | $23,971 | $251,498 | - | 2.5% | |
| Travel | $218,595 | $161,158 | $57,437 | - | 2.0% | |
| All other expenses | $209,381 | $125,092 | $84,289 | - | 1.9% | |
| Fees: other services | $200,035 | $56,008 | $144,027 | - | 1.8% | |
| Other (as described) | CHEMICALS | $119,742 | $119,742 | - | - | 1.1% |
| Fees: accounting | $110,064 | - | $110,064 | - | 1.0% | |
| Grants outside the US | $100,000 | $100,000 | - | - | 0.9% | |
| Other employee benefits | $56,990 | $10,425 | $46,565 | - | 0.5% | |
| Other (as described) | SMALL EQUIPMENT | $49,749 | $49,749 | - | - | 0.5% |
| Interest | $48,469 | $3,012 | $45,457 | - | 0.4% | |
| Other (as described) | COMPUTERS/ACCESSORIES | $41,609 | $39,486 | $2,123 | - | 0.4% |
| Pension plan contributions | $35,672 | $26,718 | $8,954 | - | 0.3% | |
| Insurance | $30,930 | - | $30,930 | - | 0.3% | |
| Conferences, conventions and meetings | $15,605 | $13,330 | $2,275 | - | 0.1% | |
| Total | $11,000,339 | 100% |
Federal grants and contracts
Awards from USAspending.gov to a recipient with this organization's name and zip code. Obligations by federal fiscal year (October to September); each award links to its page on usaspending.gov.
| Fiscal year | Grants and other assistance | Contracts | Awards |
|---|---|---|---|
| 2026 | $11,574,086 | $0 | 23 |
| 2025 | $9,499,141 | $0 | 17 |
| 2024 | $9,611,450 | $0 | 25 |
| 2023 | $8,850,606 | -$14,700 | 22 |
| 2022 | $6,747,933 | $0 | 13 |
| 2021 | $7,330,322 | -$7,500 | 20 |
| 2020 | $5,681,195 | -$1,214,164 | 17 |
| 2019 | $5,271,098 | $2,362,880 | 15 |
| 2018 | $4,954,661 | $3,511,484 | 17 |
| 2017 | $4,447,488 | $5,594,680 | 15 |
| 2016 | $3,429,982 | $882,000 | 8 |
| 2015 | $3,654,082 | $800,960 | 10 |
| 2014 | $1,323,175 | $975,000 | 5 |
| 2013 | $240,983 | $0 | 2 |
| 2012 | $131,118 | $0 | 2 |
Largest awards · 163 shown
| Year | Agency | Kind | Program | Description | Obligated |
|---|---|---|---|---|---|
| 2026 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | UNDERSTANDING SCHIZOPHRENIA RISK MECHANISMS VIA MULTIMODAL ANALYSIS OF PATIENT-DERIVED NEURONS AND 3D CORTICAL ORGANOIDS AND CORRELATION WITH CLINICAL AND COGNI | $2,566,326 |
| 2026 | National Institutes of Health | Grant or other assistance | DRUG USE AND ADDICTION RESEARCH PROGRAMS 93.279 | CELLULAR RESOLUTION SPATIO-MOLECULAR EXPRESSION ACROSS THE ANTERIOR-POSTERIOR AXIS OF THE NUCLEUS ACCUMBENS IN THE HUMAN BRAIN - PROJECT SUMMARY THE NUCLEUS ACC | $1,855,264 |
| 2026 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | MATERNAL SARS-COV-2 INFECTION, PLACENTA BIOLOGY, AND NEURODEVELOPMENTAL OUTCOMES IN THE OFFSPRING - PROJECT SUMMARY THE EXTENT TO WHICH SARS-COV-2 INFECTION IN | $1,460,609 |
| 2026 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | 1/2 LARGE-SCALE, SINGLE-CELL CHARACTERIZATION OF MOLECULAR AND CELLULAR NETWORKS OF MOOD REGULATION CIRCUITRY IN MAJOR DEPRESSIVE DISORDER - WHILE THERE IS STRO | $1,039,771 |
| 2026 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | SMALL-MOLECULE PROBES FOR AUGMENTING D5 RECEPTOR SIGNALING - PROJECT SUMMARY COGNITIVE IMPAIRMENT IS A CORE FEATURE OF MANY NEUROPSYCHIATRIC DISORDERS THAT DIRE | $839,517 |
| 2026 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | IMPACT OF NEUROMELANIN AND TAU ACCUMULATION DURING AGING AND DISEASE ON LOCAL GENE EXPRESSION IN THE HUMAN LOCUS COERULEUS USING SPATIALLY-RESOLVED TRANSCRIPTOM | $838,150 |
| 2026 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | 2/3 UNDERSTANDING PTSD THROUGH POSTMORTEM TARGETED BRAIN MULTI-OMICS | $797,817 |
| 2026 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | VALIDATION OF ELECTROPHYSIOLOGICAL BIOMARKERS ASSOCIATED WITH PERFORMANCE IN A PRECLINICAL ASSAY OF SUSTAINED ATTENTION - PROJECT SUMMARY SUSTAINED ATTENTION, T | $762,036 |
| 2026 | National Institutes of Health | Grant or other assistance | DRUG USE AND ADDICTION RESEARCH PROGRAMS 93.279 | REGULATION OF GENE EXPRESSION IN THE HUMAN HABENULA IN COMORBID OPIOID ADDICTION AND DEPRESSION - PROJECT SUMMARY/ABSTRACT DRUG ADDICTION IS HIGHLY COMORBID WIT | $680,018 |
| 2026 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | SYSTEMATIC UNDERSTANDING OF RNA-CENTRIC MECHANISMS OF GENE REGULATION IN CHROMATIN - A MAJOR FOCUS OF MODERN RNA RESEARCH IS TO UNDERSTAND ITS REGULATORY ROLES | $459,250 |
| 2026 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | A TRANSLATIONAL APPROACH TO REVEALING STRESS SUSCEPTIBILITY IN AMYGDALA-PREFRONTAL CIRCUITS - PROJECT SUMMARY/ABSTRACT POSTTRAUMATIC STRESS DISORDER (PTSD) IS A | $114,200 |
| 2026 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853 | IDENTIFYING A FUNCTIONAL ROLE FOR TRANSCRIPTIONALLY DISTINCT, BLA-ACTIVATED LS ENSEMBLES IN SOCIAL BEHAVIORS - PROJECT SUMMARY SOCIAL RECOGNITION IS THE ABILIT | $81,780 |
| 2026 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | INVESTIGATING THE EFFECTS OF TCF4 MUTATIONS DURING OLIGODENDROCYTE DEVELOPMENT AND MATURATION IN A HUMAN-DERIVED MODEL OF AUTISM SPECTRUM DISORDER - PROJECT SUM | $79,348 |
| 2025 | National Institutes of Health | Grant or other assistance | CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH 93.865 | MATERNAL SARS-COV-2 INFECTION, PLACENTA BIOLOGY, AND NEURODEVELOPMENTAL OUTCOMES IN THE OFFSPRING - PROJECT SUMMARY THE EXTENT TO WHICH SARS-COV-2 INFECTION IN | $1,451,606 |
| 2025 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | 1/2 LARGE-SCALE, SINGLE-CELL CHARACTERIZATION OF MOLECULAR AND CELLULAR NETWORKS OF MOOD REGULATION CIRCUITRY IN MAJOR DEPRESSIVE DISORDER - WHILE THERE IS STRO | $1,074,074 |
| 2025 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | 2/3 UNDERSTANDING PTSD THROUGH POSTMORTEM TARGETED BRAIN MULTI-OMICS | $897,129 |
| 2025 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | UNDERSTANDING SCHIZOPHRENIA RISK MECHANISMS VIA MULTIMODAL ANALYSIS OF PATIENT-DERIVED NEURONS AND 3D CORTICAL ORGANOIDS AND CORRELATION WITH CLINICAL AND COGNI | $878,597 |
| 2025 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | SMALL-MOLECULE PROBES FOR AUGMENTING D5 RECEPTOR SIGNALING - PROJECT SUMMARY COGNITIVE IMPAIRMENT IS A CORE FEATURE OF MANY NEUROPSYCHIATRIC DISORDERS THAT DIRE | $832,301 |
| 2025 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | IMPACT OF NEUROMELANIN AND TAU ACCUMULATION DURING AGING AND DISEASE ON LOCAL GENE EXPRESSION IN THE HUMAN LOCUS COERULEUS USING SPATIALLY-RESOLVED TRANSCRIPTOM | $830,805 |
| 2025 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | VALIDATION OF ELECTROPHYSIOLOGICAL BIOMARKERS ASSOCIATED WITH PERFORMANCE IN A PRECLINICAL ASSAY OF SUSTAINED ATTENTION - PROJECT SUMMARY SUSTAINED ATTENTION, T | $762,036 |
| 2025 | National Institutes of Health | Grant or other assistance | DRUG USE AND ADDICTION RESEARCH PROGRAMS 93.279 | REGISTRATION OF SPATIAL GENE EXPRESSION IN KEY NODES OF REWARD-RELATED CIRCUITRY IN THE HUMAN BRAIN - PROJECT SUMMARY DRUG ADDICTION IS HIGHLY COMORBID WITH PSY | $690,859 |
| 2025 | National Institutes of Health | Grant or other assistance | DRUG USE AND ADDICTION RESEARCH PROGRAMS 93.279 | REGULATION OF GENE EXPRESSION IN THE HUMAN HABENULA IN COMORBID OPIOID ADDICTION AND DEPRESSION - PROJECT SUMMARY/ABSTRACT DRUG ADDICTION IS HIGHLY COMORBID WIT | $680,018 |
| 2025 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | LAMINAR DISSECTION OF CORTICAL HUMAN BRAIN GENE EXPRESSION IN NEUROPSYCHIATRIC DISORDERS - PROJECT SUMMARY/ABSTRACT THE DLPFC IS A TRUE SIX LAYERED NEOCORTEX, A | $677,158 |
| 2025 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | SYSTEMATIC UNDERSTANDING OF RNA-CENTRIC MECHANISMS OF GENE REGULATION IN CHROMATIN - A MAJOR FOCUS OF MODERN RNA RESEARCH IS TO UNDERSTAND ITS REGULATORY ROLES | $459,250 |
| 2025 | National Institutes of Health | Grant or other assistance | DRUG USE AND ADDICTION RESEARCH PROGRAMS 93.279 | INTEGRATED SINGLE CELL AND SPATIAL MAPPING OF HABENULA CIRCUITRY TO IDENTIFY PROJECTION-SPECIFIC MOLECULAR PATHWAYS ASSOCIATED WITH OPIOID EXPOSURE. - PROJECT S | $222,170 |
| 2025 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | INVESTIGATING TCF4 AND SYNAPTIC DYSFUNCTION IN PITT-HOPKINS SYNDROME - PROJECT SUMMARY AUTISM SPECTRUM DISORDERS (ASDS) PRESENT A COMPLEX ARRAY OF NEURODEVELOPM | $43,138 |
| 2024 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | MATERNAL SARS-COV-2 INFECTION, PLACENTA BIOLOGY, AND NEURODEVELOPMENTAL OUTCOMES IN THE OFFSPRING - PROJECT SUMMARY THE EXTENT TO WHICH SARS-COV-2 INFECTION IN | $1,431,755 |
| 2024 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | UNDERSTANDING SCHIZOPHRENIA RISK MECHANISMS VIA MULTIMODAL ANALYSIS OF PATIENT-DERIVED NEURONS AND 3D CORTICAL ORGANOIDS AND CORRELATION WITH CLINICAL AND COGNI | $908,174 |
| 2024 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | IMPACT OF NEUROMELANIN AND TAU ACCUMULATION DURING AGING AND DISEASE ON LOCAL GENE EXPRESSION IN THE HUMAN LOCUS COERULEUS USING SPATIALLY-RESOLVED TRANSCRIPTOM | $867,306 |
| 2024 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | SMALL-MOLECULE PROBES FOR AUGMENTING D5 RECEPTOR SIGNALING - PROJECT SUMMARY COGNITIVE IMPAIRMENT IS A CORE FEATURE OF MANY NEUROPSYCHIATRIC DISORDERS THAT DIRE | $837,713 |
| 2024 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | LAMINAR DISSECTION OF CORTICAL HUMAN BRAIN GENE EXPRESSION IN NEUROPSYCHIATRIC DISORDERS - PROJECT SUMMARY/ABSTRACT THE DLPFC IS A TRUE SIX LAYERED NEOCORTEX, A | $821,142 |
| 2024 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | VALIDATION OF ELECTROPHYSIOLOGICAL BIOMARKERS ASSOCIATED WITH PERFORMANCE IN A PRECLINICAL ASSAY OF SUSTAINED ATTENTION - PROJECT SUMMARY SUSTAINED ATTENTION, T | $753,016 |
| 2024 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | 1/2 LARGE-SCALE, SINGLE-CELL CHARACTERIZATION OF MOLECULAR AND CELLULAR NETWORKS OF MOOD REGULATION CIRCUITRY IN MAJOR DEPRESSIVE DISORDER - WHILE THERE IS STRO | $702,401 |
| 2024 | National Institutes of Health | Grant or other assistance | DRUG ABUSE AND ADDICTION RESEARCH PROGRAMS 93.279 | REGISTRATION OF SPATIAL GENE EXPRESSION IN KEY NODES OF REWARD-RELATED CIRCUITRY IN THE HUMAN BRAIN - PROJECT SUMMARY DRUG ADDICTION IS HIGHLY COMORBID WITH PSY | $681,004 |
| 2024 | National Institutes of Health | Grant or other assistance | DRUG ABUSE AND ADDICTION RESEARCH PROGRAMS 93.279 | REGULATION OF GENE EXPRESSION IN THE HUMAN HABENULA IN COMORBID OPIOID ADDICTION AND DEPRESSION - PROJECT SUMMARY/ABSTRACT DRUG ADDICTION IS HIGHLY COMORBID WIT | $671,089 |
| 2024 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | CELLULAR AND MOLECULAR ANALYSIS OF THE SCHIZOPHRENIA AND AUTISM SPECTRUM DISORDER GENE TRANSCRIPTION FACTOR 4 (TCF4) | $636,290 |
| 2024 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | REGULATION OF NEURAL ACTIVITY IN FEAR CIRCUITS BY PROMOTER IV DERIVED BDNF | $572,834 |
| 2024 | National Institutes of Health | Grant or other assistance | DRUG ABUSE AND ADDICTION RESEARCH PROGRAMS 93.279 | INTEGRATED SINGLE CELL AND SPATIAL MAPPING OF HABENULA CIRCUITRY TO IDENTIFY PROJECTION-SPECIFIC MOLECULAR PATHWAYS ASSOCIATED WITH OPIOID EXPOSURE. - PROJECT S | $284,040 |
| 2024 | National Institutes of Health | Grant or other assistance | MINORITY HEALTH AND HEALTH DISPARITIES RESEARCH 93.307 | COMPREHENSIVE COMPUTATIONAL ANALYSIS OF GENETIC AND REGULATORY DIFFERENCES BETWEEN INDIVIDUALS WITH AFRICAN AND EUROPEAN ANCESTRIES ACROSS FOUR BRAIN REGIONS - | $249,000 |
| 2024 | National Institutes of Health | Grant or other assistance | 21ST CENTURY CURES ACT - BRAIN RESEARCH THROUGH ADVANCING INNOVATIVE NEUROTECHNOLOGIES 93.372 | IDENTIFYING A FUNCTIONAL ROLE FOR TRANSCRIPTIONALLY DISTINCT, BLA-ACTIVATED LS ENSEMBLES IN SOCIAL BEHAVIORS - PROJECT SUMMARY SOCIAL RECOGNITION IS THE ABILIT | $78,828 |
| 2024 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | INVESTIGATING THE EFFECTS OF TCF4 MUTATIONS DURING OLIGODENDROCYTE DEVELOPMENT AND MATURATION IN A HUMAN-DERIVED MODEL OF AUTISM SPECTRUM DISORDER - PROJECT SUM | $74,284 |
| 2024 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | INVESTIGATING TCF4 AND SYNAPTIC DYSFUNCTION IN PITT-HOPKINS SYNDROME - PROJECT SUMMARY AUTISM SPECTRUM DISORDERS (ASDS) PRESENT A COMPLEX ARRAY OF NEURODEVELOPM | $42,574 |
| 2023 | National Institutes of Health | Grant or other assistance | CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH 93.865 | MATERNAL SARS-COV-2 INFECTION, PLACENTA BIOLOGY, AND NEURODEVELOPMENTAL OUTCOMES IN THE OFFSPRING - PROJECT SUMMARY THE EXTENT TO WHICH SARS-COV-2 INFECTION IN | $1,444,001 |
| 2023 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | SMALL-MOLECULE PROBES FOR AUGMENTING D5 RECEPTOR SIGNALING - PROJECT SUMMARY COGNITIVE IMPAIRMENT IS A CORE FEATURE OF MANY NEUROPSYCHIATRIC DISORDERS THAT DIRE | $837,713 |
| 2023 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | LAMINAR DISSECTION OF CORTICAL HUMAN BRAIN GENE EXPRESSION IN NEUROPSYCHIATRIC DISORDERS - PROJECT SUMMARY/ABSTRACT THE DLPFC IS A TRUE SIX LAYERED NEOCORTEX, A | $770,300 |
| 2023 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | REGULATION OF NEURAL ACTIVITY IN FEAR CIRCUITS BY PROMOTER IV DERIVED BDNF | $704,650 |
| 2023 | National Institutes of Health | Grant or other assistance | DRUG ABUSE AND ADDICTION RESEARCH PROGRAMS 93.279 | REGISTRATION OF SPATIAL GENE EXPRESSION IN KEY NODES OF REWARD-RELATED CIRCUITRY IN THE HUMAN BRAIN - PROJECT SUMMARY DRUG ADDICTION IS HIGHLY COMORBID WITH PSY | $704,352 |
| 2023 | National Institutes of Health | Grant or other assistance | DRUG ABUSE AND ADDICTION RESEARCH PROGRAMS 93.279 | REGULATION OF GENE EXPRESSION IN THE HUMAN HABENULA IN COMORBID OPIOID ADDICTION AND DEPRESSION - PROJECT SUMMARY/ABSTRACT DRUG ADDICTION IS HIGHLY COMORBID WIT | $646,796 |
| 2023 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | CELLULAR AND MOLECULAR ANALYSIS OF THE SCHIZOPHRENIA AND AUTISM SPECTRUM DISORDER GENE TRANSCRIPTION FACTOR 4 (TCF4) | $627,592 |
| 2023 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | INTEGRATIVE CELLULAR DECONVOLUTION OF HUMAN BRAIN RNA SEQUENCING DATA | $618,221 |
| 2023 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | INTEGRATIVE APPROACHES TO IDENTIFICATION AND INTERPRETATION OF GENES UNDERLYING PSYCHIATRIC DISORDERS | $595,673 |
| 2023 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | PROFILING THE HUMAN DENTATE GYRUS ACROSS THE LIFESPAN WITH SPATIALLY-RESOLVED TRANSCRIPTOMICS - PROJECT SUMMARY THE HIPPOCAMPUS PLAYS A WELL-ESTABLISHED ROLE IN | $509,389 |
| 2023 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | 1/2 LARGE-SCALE, SINGLE-CELL CHARACTERIZATION OF MOLECULAR AND CELLULAR NETWORKS OF MOOD REGULATION CIRCUITRY IN MAJOR DEPRESSIVE DISORDER - SUMMARY WHILE THERE | $501,468 |
| 2023 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | MODELING SCHIZOPHRENIA WITH PATIENT-SPECIFIC MUTATIONS IN GRIN2A AND SP4 - PROJECT SUMMARY: SCHIZOPHRENIA (SCZ) IS A COMMON AND DEBILITATING MENTAL ILLNESS CHAR | $496,100 |
| 2023 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | MOLECULAR, CELLULAR AND PHYSIOLOGICAL CORRELATES OF SUSTAINED ATTENTION IN THE LOCUS COERULEUS TO ANTERIOR CINGULATE CORTEX CIRCUIT - PROJECT SUMMARY SUSTAINED | $443,671 |
| 2023 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | DISSECTING MODULAR INTERACTION OF RNA WITH PROTEIN IN CHROMATIN - PROJECT SUMMARY / ABSTRACT THE FOREFRONT OF CURRENT RNA RESEARCH CENTERS ON UNDERSTANDING THE | $248,930 |
| 2023 | National Institutes of Health | Grant or other assistance | MINORITY HEALTH AND HEALTH DISPARITIES RESEARCH 93.307 | COMPREHENSIVE COMPUTATIONAL ANALYSIS OF GENETIC AND REGULATORY DIFFERENCES BETWEEN INDIVIDUALS WITH AFRICAN AND EUROPEAN ANCESTRIES ACROSS FOUR BRAIN REGIONS - | $97,134 |
| 2023 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | NEURAL SUBSTRATES OF EXTINCTION DEFICITS IN PATHOLOGICAL FEAR - POSTTRAUMATIC STRESS DISORDER (PTSD) IS A COMMON PSYCHIATRIC CONDITION THAT AFFECTS MILLIONS OF | $69,080 |
| 2023 | Department of Veterans Affairs | Contract | RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) 541715 | BRAIN TISSUE SEQUENCING AND DATA ANALYSIS | -$14,700 |
| 2023 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | REGULATION OF FEAR EXPRESSION BY ACTIVITY-DEPENDENT BDNF IN DIRECT HIPPOCAMPAL-TO-PRELIMBIC PROJECTIONS | -$73,709 |
| 2023 | National Institutes of Health | Grant or other assistance | ALCOHOL RESEARCH PROGRAMS 93.273 | A SYSTEMS APPROACH TO THE GENETIC STUDY OF ALCOHOL DEPENDENCE | -$390,754 |
| 2022 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | LAMINAR DISSECTION OF CORTICAL HUMAN BRAIN GENE EXPRESSION IN NEUROPSYCHIATRIC DISORDERS - PROJECT SUMMARY/ABSTRACT THE DLPFC IS A TRUE SIX LAYERED NEOCORTEX, A | $802,692 |
| 2022 | National Institutes of Health | Grant or other assistance | DRUG ABUSE AND ADDICTION RESEARCH PROGRAMS 93.279 | REGISTRATION OF SPATIAL GENE EXPRESSION IN KEY NODES OF REWARD-RELATED CIRCUITRY IN THE HUMAN BRAIN - PROJECT SUMMARY DRUG ADDICTION IS HIGHLY COMORBID WITH PSY | $796,604 |
| 2022 | National Institutes of Health | Grant or other assistance | CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH 93.865 | MATERNAL SARS-COV-2 INFECTION, PLACENTA BIOLOGY, AND NEURODEVELOPMENTAL OUTCOMES IN THE OFFSPRING - PROJECT SUMMARY THE EXTENT TO WHICH SARS-COV-2 INFECTION IN | $757,935 |
| 2022 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | REGULATION OF NEURAL ACTIVITY IN FEAR CIRCUITS BY PROMOTER IV DERIVED BDNF | $708,556 |
| 2022 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | 2/3 UNDERSTANDING PTSD THROUGH POSTMORTEM TARGETED BRAIN MULTI-OMICS | $686,197 |
| 2022 | National Institutes of Health | Grant or other assistance | DRUG ABUSE AND ADDICTION RESEARCH PROGRAMS 93.279 | REGULATION OF GENE EXPRESSION IN THE HUMAN HABENULA IN COMORBID OPIOID ADDICTION AND DEPRESSION - PROJECT SUMMARY/ABSTRACT DRUG ADDICTION IS HIGHLY COMORBID WIT | $667,421 |
| 2022 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | CELLULAR AND MOLECULAR ANALYSIS OF THE SCHIZOPHRENIA AND AUTISM SPECTRUM DISORDER GENE TRANSCRIPTION FACTOR 4 (TCF4) | $636,105 |
| 2022 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | INTEGRATIVE APPROACHES TO IDENTIFICATION AND INTERPRETATION OF GENES UNDERLYING PSYCHIATRIC DISORDERS | $595,673 |
| 2022 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | INTEGRATIVE CELLULAR DECONVOLUTION OF HUMAN BRAIN RNA SEQUENCING DATA | $554,604 |
| 2022 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | DISSECTING MODULAR INTERACTION OF RNA WITH PROTEIN IN CHROMATIN - PROJECT SUMMARY / ABSTRACT THE FOREFRONT OF CURRENT RNA RESEARCH CENTERS ON UNDERSTANDING THE | $261,146 |
| 2022 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | PLACENTAL TRANSCRIPTOMICS AND RISK FOR SCHIZOPHRENIA - OUR MAIN OBJECTIVE IS TO FIND THE FACTORS MEDIATING THE RELATIONSHIP BETWEEN GENETIC RISK FACTORS, COMPLI | $181,000 |
| 2022 | National Institutes of Health | Grant or other assistance | MINORITY HEALTH AND HEALTH DISPARITIES RESEARCH 93.307 | COMPREHENSIVE COMPUTATIONAL ANALYSIS OF GENETIC AND REGULATORY DIFFERENCES BETWEEN INDIVIDUALS WITH AFRICAN AND EUROPEAN ANCESTRIES ACROSS FOUR BRAIN REGIONS - | $100,000 |
| 2021 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | LAMINAR DISSECTION OF CORTICAL HUMAN BRAIN GENE EXPRESSION IN NEUROPSYCHIATRIC DISORDERS - PROJECT SUMMARY/ABSTRACT THE DLPFC IS A TRUE SIX LAYERED NEOCORTEX, A | $844,939 |
| 2021 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | SPATIAL REGISTRATION OF GENE EXPRESSION IN THE HUMAN BRAIN | $842,796 |
| 2021 | National Institutes of Health | Grant or other assistance | DRUG ABUSE AND ADDICTION RESEARCH PROGRAMS 93.279 | REGISTRATION OF SPATIAL GENE EXPRESSION IN KEY NODES OF REWARD-RELATED CIRCUITRY IN THE HUMAN BRAIN - PROJECT SUMMARY DRUG ADDICTION IS HIGHLY COMORBID WITH PSY | $821,650 |
| 2021 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | 2/3 UNDERSTANDING PTSD THROUGH POSTMORTEM TARGETED BRAIN MULTI-OMICS | $717,348 |
| 2021 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | NEUROPHYSIOLOGICAL BIOMARKERS IN PRECLINICAL ASSAYS OF SUSTAINED ATTENTION - PROJECT SUMMARY SUSTAINED ATTENTION, THE ABILITY TO FOCUS ON AN ACTIVITY OR STIMULU | $654,255 |
| 2021 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | REGULATION OF NEURAL ACTIVITY IN FEAR CIRCUITS BY PROMOTER IV DERIVED BDNF | $649,471 |
| 2021 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | CELLULAR AND MOLECULAR ANALYSIS OF THE SCHIZOPHRENIA AND AUTISM SPECTRUM DISORDER GENE TRANSCRIPTION FACTOR 4 (TCF4) | $640,414 |
| 2021 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | INTEGRATIVE APPROACHES TO IDENTIFICATION AND INTERPRETATION OF GENES UNDERLYING PSYCHIATRIC DISORDERS | $595,673 |
| 2021 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | INTEGRATIVE CELLULAR DECONVOLUTION OF HUMAN BRAIN RNA SEQUENCING DATA | $507,442 |
| 2021 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | FUNCTIONAL METHYLOMICS APPROACHES FOR SCHIZOPHRENIA IN THE FRONTAL CORTEX AND HIPPOCAMPUS | $418,024 |
| 2021 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | PLACENTAL TRANSCRIPTOMICS AND RISK FOR SCHIZOPHRENIA - OUR MAIN OBJECTIVE IS TO FIND THE FACTORS MEDIATING THE RELATIONSHIP BETWEEN GENETIC RISK FACTORS, COMPLI | $316,750 |
| 2021 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | DISSECTING MODULAR INTERACTION OF RNA WITH PROTEIN IN CHROMATIN - PROJECT SUMMARY / ABSTRACT THE FOREFRONT OF CURRENT RNA RESEARCH CENTERS ON UNDERSTANDING THE | $248,930 |
| 2021 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | REGULATION OF FEAR EXPRESSION BY ACTIVITY-DEPENDENT BDNF IN DIRECT HIPPOCAMPAL-TO-PRELIMBIC PROJECTIONS | $72,630 |
| 2021 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | IGF::OT::IGF PTSD BRAIN HEMISPHERES | -$7,500 |
| 2020 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | SPATIAL REGISTRATION OF GENE EXPRESSION IN THE HUMAN BRAIN | $904,464 |
| 2020 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | CELLULAR AND MOLECULAR ANALYSIS OF THE SCHIZOPHRENIA AND AUTISM SPECTRUM DISORDER GENE TRANSCRIPTION FACTOR 4 (TCF4) | $791,545 |
| 2020 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | 2/3 UNDERSTANDING PTSD THROUGH POSTMORTEM TARGETED BRAIN MULTI-OMICS | $717,348 |
| 2020 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | REGULATION OF NEURAL ACTIVITY IN FEAR CIRCUITS BY PROMOTER IV DERIVED BDNF | $678,813 |
| 2020 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | INTEGRATIVE APPROACHES TO IDENTIFICATION AND INTERPRETATION OF GENES UNDERLYING PSYCHIATRIC DISORDERS | $647,274 |
| 2020 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | INTEGRATIVE CELLULAR DECONVOLUTION OF HUMAN BRAIN RNA SEQUENCING DATA | $620,747 |
| 2020 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | FUNCTIONAL METHYLOMICS APPROACHES FOR SCHIZOPHRENIA IN THE FRONTAL CORTEX AND HIPPOCAMPUS | $418,024 |
| 2020 | National Institutes of Health | Grant or other assistance | ALCOHOL RESEARCH PROGRAMS 93.273 | A SYSTEMS APPROACH TO THE GENETIC STUDY OF ALCOHOL DEPENDENCE | $390,754 |
| 2020 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | AN EXPANDED FRAMEWORK FOR RNA QUALITY CORRECTION IN EXPRESSION ANALYSES IN THE HUMAN BRAIN | $233,250 |
| 2020 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | TEMPORAL COHERENCE OF SCHIZOPHRENIA RISK GENES IN A CRITICAL BRAIN CIRCUIT: IT'S ABOUT TIME | $209,670 |
| 2020 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | REGULATION OF FEAR EXPRESSION BY ACTIVITY-DEPENDENT BDNF IN DIRECT HIPPOCAMPAL-TO-PRELIMBIC PROJECTIONS | $69,306 |
| 2020 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | IGF::OT::IGF POSTMORTEM HUMAN BRAIN HEMISPHERES | -$333,664 |
| 2020 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | IGF::OT::IGF PTSD BRAIN HEMISPHERES | -$880,500 |
| 2019 | Department of Veterans Affairs | Contract | RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) 541715 | BRAIN TISSUE SEQUENCING AND DATA ANALYSIS | $2,362,880 |
| 2019 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | FUNCTIONAL METHYLOMICS APPROACHES FOR SCHIZOPHRENIA IN THE FRONTAL CORTEX AND HIPPOCAMPUS | $839,987 |
| 2019 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | DRUG DISCOVERY OF COMT INHIBITORS TO TREAT COGNITIVE DEFICITS IN SCHIZOPHRENIA | $779,257 |
| 2019 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | 2/3 UNDERSTANDING PTSD THROUGH POSTMORTEM TARGETED BRAIN MULTI-OMICS | $700,263 |
| 2019 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | BSMN REFERENCE TISSUE PROJECT (LIEBER INSTITUTE FOR BRAIN DEVELOPMENT) 1U01MH106893-01 - 1/3-SCHIZOPHRENIA GENETICS AND BRAIN SOMATIC MOSAICISM | $696,225 |
| 2019 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | REGULATION OF NEURAL ACTIVITY IN FEAR CIRCUITS BY PROMOTER IV DERIVED BDNF | $462,500 |
| 2019 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | CELLULAR AND MOLECULAR ANALYSIS OF THE SCHIZOPHRENIA AND AUTISM SPECTRUM DISORDER GENE TRANSCRIPTION FACTOR 4 (TCF4) | $456,500 |
| 2019 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | HIGH THROUGHPUT SCREENING TO DISCOVER INHIBITORS FOR IP6K1 AS A POTENTIAL TREATMENT FOR PSYCHIATRIC DISORDERS | $456,500 |
| 2019 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | AN EXPANDED FRAMEWORK FOR RNA QUALITY CORRECTION IN EXPRESSION ANALYSES IN THE HUMAN BRAIN | $279,900 |
| 2019 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | EPIGENOMIC CONTRIBUTION TO THE ANTIDEPRESSANT RESPONSE | $279,900 |
| 2019 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | TEMPORAL COHERENCE OF SCHIZOPHRENIA RISK GENES IN A CRITICAL BRAIN CIRCUIT: IT'S ABOUT TIME | $256,320 |
| 2019 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | REGULATION OF FEAR EXPRESSION BY ACTIVITY-DEPENDENT BDNF IN DIRECT HIPPOCAMPAL-TO-PRELIMBIC PROJECTIONS | $63,746 |
| 2018 | Department of Veterans Affairs | Contract | RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) 541715 | BRAIN TISSUE SEQUENCING AND DATA ANALYSIS | $2,362,880 |
| 2018 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | IGF::OT::IGF PTSD BRAIN HEMISPHERES | $888,000 |
| 2018 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | FUNCTIONAL METHYLOMICS APPROACHES FOR SCHIZOPHRENIA IN THE FRONTAL CORTEX AND HIPPOCAMPUS | $856,900 |
| 2018 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | DRUG DISCOVERY OF COMT INHIBITORS TO TREAT COGNITIVE DEFICITS IN SCHIZOPHRENIA | $787,626 |
| 2018 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | 2/3 UNDERSTANDING PTSD THROUGH POSTMORTEM TARGETED BRAIN MULTI-OMICS | $700,263 |
| 2018 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | BSMN REFERENCE TISSUE PROJECT (LIEBER INSTITUTE FOR BRAIN DEVELOPMENT) 1U01MH106893-01 - 1/3-SCHIZOPHRENIA GENETICS AND BRAIN SOMATIC MOSAICISM | $696,225 |
| 2018 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | REGULATION OF NEURAL ACTIVITY IN FEAR CIRCUITS BY PROMOTER IV DERIVED BDNF | $462,500 |
| 2018 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | CELLULAR AND MOLECULAR ANALYSIS OF THE SCHIZOPHRENIA AND AUTISM SPECTRUM DISORDER GENE TRANSCRIPTION FACTOR 4 (TCF4) | $456,500 |
| 2018 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | HIGH THROUGHPUT SCREENING TO DISCOVER INHIBITORS FOR IP6K1 AS A POTENTIAL TREATMENT FOR PSYCHIATRIC DISORDERS | $456,500 |
| 2018 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | KCNH2-3.1 POTASSIUM CHANNEL AND SCHIZOPHRENIA. | $305,255 |
| 2018 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | HUMAN BRAIN HEMISPHERES | $260,604 |
| 2018 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | EPIGENOMIC CONTRIBUTION TO THE ANTIDEPRESSANT RESPONSE | $233,250 |
| 2018 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | ESTABLISHING COMPREHENSIVE AND QUANTITATIVE MAPS OF DNA METHYLATION IN THE DEVELO | -$358 |
| 2017 | Department of Veterans Affairs | Contract | MEDICAL LABORATORIES 621511 | IGF::OT::IGF SEQUENCING SERVICES FOR BRAIN TISSUE | $3,695,000 |
| 2017 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | FUNCTIONAL METHYLOMICS APPROACHES FOR SCHIZOPHRENIA IN THE FRONTAL CORTEX AND HIPPOCAMPUS | $902,000 |
| 2017 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | IGF::OT::IGF PTSD BRAIN HEMISPHERES | $864,000 |
| 2017 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | IGF::OT::IGF POSTMORTEM HUMAN BRAIN HEMISPHERES | $819,680 |
| 2017 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | DRUG DISCOVERY OF COMT INHIBITORS TO TREAT COGNITIVE DEFICITS IN SCHIZOPHRENIA | $805,808 |
| 2017 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | BSMN REFERENCE TISSUE PROJECT (LIEBER INSTITUTE FOR BRAIN DEVELOPMENT) 1U01MH106893-01 - 1/3-SCHIZOPHRENIA GENETICS AND BRAIN SOMATIC MOSAICISM | $785,025 |
| 2017 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | REGULATION OF NEURAL ACTIVITY IN FEAR CIRCUITS BY PROMOTER IV DERIVED BDNF | $462,500 |
| 2017 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | HIGH THROUGHPUT SCREENING TO DISCOVER INHIBITORS FOR IP6K1 AS A POTENTIAL TREATMENT FOR PSYCHIATRIC DISORDERS | $456,500 |
| 2017 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | CELLULAR AND MOLECULAR ANALYSIS OF THE SCHIZOPHRENIA AND AUTISM SPECTRUM DISORDER GENE TRANSCRIPTION FACTOR 4 (TCF4) | $456,500 |
| 2017 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | KCNH2-3.1 POTASSIUM CHANNEL AND SCHIZOPHRENIA. | $305,255 |
| 2017 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | CHARACTERIZING THE DEVELOPING HUMAN BRAIN TRANSCRIPTOME AT SINGLE-BASE RESOLUTION | $273,900 |
| 2017 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | IGF::OT::IGF PTSD BRAIN HEMISPHERES | $216,000 |
| 2016 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | BSMN REFERENCE TISSUE PROJECT (LIEBER INSTITUTE FOR BRAIN DEVELOPMENT) 1U01MH106893-01 - 1/3-SCHIZOPHRENIA GENETICS AND BRAIN SOMATIC MOSAICISM | $1,029,456 |
| 2016 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | IGF::OT::IGF PTSD BRAIN HEMISPHERES | $882,000 |
| 2016 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | DRUG DISCOVERY OF COMT INHIBITORS TO TREAT COGNITIVE DEFICITS IN SCHIZOPHRENIA | $809,271 |
| 2016 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | REGULATION OF NEURAL ACTIVITY IN FEAR CIRCUITS BY PROMOTER IV DERIVED BDNF | $462,500 |
| 2016 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | CELLULAR AND MOLECULAR ANALYSIS OF THE SCHIZOPHRENIA AND AUTISM SPECTRUM DISORDER GENE TRANSCRIPTION FACTOR 4 (TCF4) | $456,500 |
| 2016 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | KCNH2-3.1 POTASSIUM CHANNEL AND SCHIZOPHRENIA. | $305,255 |
| 2016 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | CHARACTERIZING THE DEVELOPING HUMAN BRAIN TRANSCRIPTOME AT SINGLE-BASE RESOLUTION | $228,250 |
| 2016 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | DECOMPOSING CELL TYPE-SPECIFIC MARKS IN POST-MORTEM HUMAN BRAIN STUDIES | $138,750 |
| 2015 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | DRUG DISCOVERY OF COMT INHIBITORS TO TREAT COGNITIVE DEFICITS IN SCHIZOPHRENIA | $915,650 |
| 2015 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | IGF::OT::IGF BRAIN HEMISPHERES | $800,960 |
| 2015 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | BSMN REFERENCE TISSUE PROJECT (LIEBER INSTITUTE FOR BRAIN DEVELOPMENT) 1U01MH106893-01 - 1/3-SCHIZOPHRENIA GENETICS AND BRAIN SOMATIC MOSAICISM | $724,867 |
| 2015 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | REGULATION OF NEURAL ACTIVITY IN FEAR CIRCUITS BY PROMOTER IV DERIVED BDNF | $462,500 |
| 2015 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | FUNCTIONAL ANALYSIS OF THE SCHIZOPHRENIA AND AUTISM SPECTRUM DISORDER GENE TCF4 I | $457,500 |
| 2015 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | DECOMPOSING CELL TYPE-SPECIFIC MARKS IN POST-MORTEM HUMAN BRAIN STUDIES | $370,000 |
| 2015 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | KCNH2-3.1 POTASSIUM CHANNEL AND SCHIZOPHRENIA. | $305,255 |
| 2015 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | ESTABLISHING COMPREHENSIVE AND QUANTITATIVE MAPS OF DNA METHYLATION IN THE DEVELO | $229,750 |
| 2015 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | EFFECTS OF GENES AND CHILDHOOD ENVIRONMENT ON BRAIN MECHANISMS OF SCHIZOPHRENIA R | $188,560 |
| 2014 | Department of Veterans Affairs | Contract | RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY 541711 | PROCUREMENT OF MEDICAL SUPPLIES | $975,000 |
| 2014 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | FUNCTIONAL ANALYSIS OF THE SCHIZOPHRENIA AND AUTISM SPECTRUM DISORDER GENE TCF4 I | $457,500 |
| 2014 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | ESTABLISHING COMPREHENSIVE AND QUANTITATIVE MAPS OF DNA METHYLATION IN THE DEVELO | $366,000 |
| 2014 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | KCNH2-3.1 POTASSIUM CHANNEL AND SCHIZOPHRENIA. | $305,255 |
| 2014 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | EFFECTS OF GENES AND CHILDHOOD ENVIRONMENT ON BRAIN MECHANISMS OF SCHIZOPHRENIA R | $194,420 |
| 2013 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | EFFECTS OF GENES AND CHILDHOOD ENVIRONMENT ON BRAIN MECHANISMS OF SCHIZOPHRENIA R | $200,000 |
| 2013 | National Institutes of Health | Grant or other assistance | TRANS-NIH RESEARCH SUPPORT 93.310 | HIGH THROUGHPUT SCREENING FOR SPECIFIC INHIBITORS AND MODULATORS OF A NOVEL POTAS | $40,983 |
| 2012 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH CAREER/SCIENTIST DEVELOPMENT AWARDS 93.281 | THE ROLE OF DISC 1 IN SYNAPSE FORMATION & FUNCTION IN THE DEVELOPING NEOCORTEX | $88,868 |
| 2012 | National Institutes of Health | Grant or other assistance | TRANS-NIH RESEARCH SUPPORT 93.310 | HIGH THROUGHPUT SCREENING FOR SPECIFIC INHIBITORS AND MODULATORS OF A NOVEL POTAS | $42,250 |
State business registration
- LIEBER INSTITUTE, INC. MD, Employee benefit plan sponsor (Form 5500), Filed for plan year 2025
The same business name in the same state, from the state’s official registry data.
Patents
9 US patents filed in the last 20 years.
- Lieber Institute, Inc. 9 patents, 2019-04-23 to 2026-06-23 EXACT high confidence: identical full name and state
| Patent | Title | Granted | Source |
|---|---|---|---|
| US 12662482 | Compounds which inhibit RNA polymerase | 2026-06-23 | PTBLXML, file of 2026-06-23 |
| US 12234221 | Pyridine carboxamide compounds for inhibiting NAV1.8 | 2025-02-25 | PVGPATDIS, file of 2026-04-10 |
| US 12049467 | Substituted benzopyrazolo[1,5-a][1,4]diazepines as GABA positive allosteric modulators | 2024-07-30 | PVGPATDIS, file of 2026-04-10 |
| US 11993581 | Pyridazine compounds for inhibiting Nav1.8 | 2024-05-28 | PVGPATDIS, file of 2026-04-10 |
| US 11221329 | Treatment of neurological and neurodevelopmental diseases and disorders associated with aberrant ion channel expression and activity | 2022-01-11 | PVGPATDIS, file of 2026-04-10 |
| US 11136322 | Peripherally restricted GABA positive allosteric modulators for the treatment of irritable bowel syndrome and other ailments of the peripheral nervous system | 2021-10-05 | PVGPATDIS, file of 2026-04-10 |
| US 10934283 | COMT inhibiting methods and compositions | 2021-03-02 | PVGPATDIS, file of 2026-04-10 |
| US 10844070 | Peripherally restricted GABA positive allosteric modulators for the treatment of irritable bowel syndrome and other ailments of the peripheral nervous system | 2020-11-24 | PVGPATDIS, file of 2026-04-10 |
| US 10266534 | Peripherally restricted GABA positive allosteric modulators for the treatment of irritable bowel syndrome and other ailments of the peripheral nervous system | 2019-04-23 | PVGPATDIS, file of 2026-04-10 |
The newest patents of the PatentsView assignees above, matched to this record by name (and state).
Trademarks
6 US trademarks, 5 live.
- Lieber Institute, Inc. 6 marks, MD EXACT high confidence: identical full name and state
| Mark | Serial | Filed | Status | Source |
|---|---|---|---|---|
| LIEBER INSTITUTE FOR BRAIN DEVELOPMENT MALTZ RESEARCH LABORATORIES | 88506006 | 2019-07-09 | Registered | TRTDXFAP, file of 2026-05-22 |
| NEURODEVELOPMENTS | 88476498 | 2019-06-17 | Registered | TRTDXFAP, file of 2025-08-13 |
| BRAINCLOUD | 86199907 | 2014-02-21 | Registration cancelled | TRCFECO2, file of 2024-03-27 |
| LIEBER INSTITUTE FOR BRAIN DEVELOPMENT | 85821016 | 2013-01-11 | Registered and renewed | TRTYRAP, file of 2026-04-03 |
| LIEBER INSTITUTE | 85821013 | 2013-01-11 | Registration cancelled | TRTYRAP, file of 2026-04-03 |
| LIBD | 85821009 | 2013-01-11 | Registered | TRCFECO2, file of 2024-03-27 |
The newest marks of the trademark owners above, matched to this record by name (and state).
Drug and device company payments (Open Payments) Fuzzy
- Teaching hospital receiving payments: LIEBER INSTITUTE INC, $42,000 in 1 records, 2019 (same name and state)
In the news
503 news articles name this organization (April 2015 to November 2026); the latest 10:
- Helsing Unveils AI Military Targeting Platform Clarity With Human Sign-Off, No Customers Named
techtimes.com, November 12, 2026 - UN and ICRC Issue Final Warning: Autonomous Weapons Window Closes in Five Days
techtimes.com, August 26, 2026 - Mount Sinai Creates Human Antibody to Fight Nipah, Hendra
miragenews.com, June 25, 2026 - Ready or Not, AI Government is Already Here
nakedcapitalism.com, May 15, 2026 - Ready or Not, AI Government is Already Here
counterpunch.org, May 15, 2026 - Ready or Not, AI Government is Already Here
slguardian.org, May 14, 2026 - Ready Or Not, AI Government Is Already Here
scoop.co.nz, May 14, 2026 - RNA Editing Linked to Down Syndrome Brain Changes
miragenews.com, March 31, 2026 - War and the Law - Quadrant
quadrant.org.au, March 6, 2026 - Tucson Speaks Out: December 28
tucson.com, December 28, 2025
News article metadata and links: The GDELT Project (https://www.gdeltproject.org/). Matched by: Exact name match: "lieber institute". A shared name is not proof of the same organization; how the matching works. Most in the news.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Plan sponsor | LIEBER INSTITUTE, INC. | MD | Form 5500 (employee benefit plans) | EIN (EXACT) |
| Federal award recipient | LIEBER INSTITUTE INC | MD | Federal spending (USAspending) | name and state |
| Payment recipient | LIEBER INSTITUTE INC | MD | Open Payments (drug and device company payments) | name and state |
| Patent assignee | Lieber Institute, Inc. | MD | Patents (USPTO) | name and state |
| Trademark owner | Lieber Institute, Inc. | MD | Trademarks (USPTO) | name and state |
| Wikipedia article | Lieber Institute for Brain Development | Wikipedia (English) | FUZZY: the same website address and the same name |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
NTEE code Brain Disorders Research, MD first:
- THE STANLEY MEDICAL RESEARCH INSTITUTE MD
- INSTITUTE OF CHRONIC ILLNESSES INC MD
- HUGH AND CAROLYN SHELTON MILITARY NEUROTRAUMA FOUNDATION MD
- MOSES MAX MINDKNIT RESEARCH CENTER MD
- BRAIN HEALTH EDUCATION AND RESEARCH INSTITUTE MD
- GREEN WAVE FOUNDATION INC MD
- NEUROSENSORY NEUROREGENERATIVE RESEARCH FOUNDATION MD
- LANEY JAYMES FOUNDATION MD
- CORY HEIDARAN CHARITABLE FOUNDATION MD
- INVISIBLE SCAR FOUNDATION MD
In other datasets, the same topic (Medical research) in MD:
- Form D issuer: 20/20 GeneSystems, Inc. (Form D private offerings)
- IPO registrant: BIORELIANCE CORP (IPO registrations (S-1, F-1))
Interests: Brain Disorders Research · science:research_education · Medical research
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Census Tract 2604.04, Baltimore city, Maryland, place (city or town) Baltimore, MD, county Baltimore city, MD, state Maryland; placed by its ZIP code (county and tract) and city name (place). The tract is the tract holding most of the record's ZIP code (FURP does not geocode street addresses).
- DANIEL R WEINBERGER was paid $791,111, 12.7 times the median household income in Baltimore, MD ($62,177), where 19.7% of residents live in poverty.
- Revenue of $33,169,343 is $58 per resident of Baltimore, MD (population 573,243).
- That revenue equals 0.21% of all household income in Baltimore, MD (255,668 households at the median $62,177, about $15,896,669,236).
- 142 employees is 0.2 per 1,000 residents of Baltimore, MD.
| Measure | Census tract Census Tract 2604.04, Baltimore city, Maryland | Place (city or town) Baltimore, MD | County Baltimore city, MD | State Maryland |
|---|---|---|---|---|
| Population B01003 | 1,778 | 573,243 | 573,243 | 6,206,011 |
| Population, 2020 census P1 | 2,256 | 585,708 | 585,708 | 6,177,224 |
| Median age B01002 | 33.1 | 36.2 | 36.2 | 39.4 |
| Under 18 B01001 | 30.8% | 20.9% | 20.9% | 22.2% |
| 65 and over B01001 | 8.3% | 15.3% | 15.3% | 16.7% |
| Households B11001 | 454 | 255,668 | 255,668 | 2,362,928 |
| Foreign born B05002 | 34.8% | 9.3% | 9.3% | 16.6% |
| Median household income B19013 | $55,921 | $62,177 | $62,177 | $103,678 |
| Median family income B19113 | $57,039 | $76,243 | $76,243 | $127,817 |
| Per capita income B19301 | $16,414 | $40,604 | $40,604 | $52,979 |
| Poverty rate B17001 | 32.5% | 19.7% | 19.7% | 9.4% |
| Unemployment rate B23025 | 8.0% | 6.5% | 6.5% | 4.9% |
| Civilian labor force B23025 | 773 | 294,134 | 294,134 | 3,313,651 |
| Mean commute (minutes) B08013 | 40.6 | 29.1 | 29.1 | 31.1 |
| Bachelor's degree or higher B15003 | 3.1% | 36.1% | 36.1% | 43.4% |
| Housing units B25001 | 688 | 295,032 | 295,032 | 2,560,784 |
| Owner-occupied B25003 | 25.8% | 47.5% | 47.5% | 67.6% |
| Renters B25003 | 74.2% | 52.5% | 52.5% | 32.4% |
| Median home value B25077 | $179,900 | $229,600 | $229,600 | $419,900 |
| Median gross rent B25064 | $1,436 | $1,331 | $1,331 | $1,705 |
| White, not Hispanic B03002 | 45.3% | 26.0% | 26.0% | 46.6% |
| Black B03002 | 9.2% | 58.5% | 58.5% | 28.9% |
| Hispanic or Latino B03002 | 42.3% | 8.2% | 8.2% | 12.5% |
| Asian B03002 | 0.0% | 2.6% | 2.6% | 6.5% |
| American Indian and Alaska Native B03002 | 0.0% | 0.2% | 0.2% | 0.1% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Census Tract 2604.04, Baltimore city, Maryland.
Comments